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ABSTRACT 
 
Saccharomyces is a genus of fungi consisting of many species of yeast strains including 
S. cerevisiae and S. boulardii, and has been engineered for implementing economic processes 
for producing biofuels and chemicals. However, this microorganism has restricted capabilities 
for producing other biomolecules than ethanol due to a rigid metabolic flux through glycolysis 
and ethanol pathway during utilization of fermentable sugars. Since the ethanol pathway plays a 
key role in cytosolic acetyl-CoA synthesis and redox balance of Saccharomyces, new metabolic 
engineering approaches not to knock out its ethanol pathway but to minimize the overflow 
metabolism are needed for increasing productivities of acetyl-CoA derivatives, growth-
dependent metabolites, and intracellular biomolecules. The overall goal of my thesis study is to 
manipulate sugar metabolisms in Saccharomyces yeast strains for developing optimal yeast 
cells capable of efficiently synthesizing value-added pharmaceutical and nutraceutical 
molecules by bypassing negative characteristics of the overflow metabolism. Two strategies for 
bypassing the native overflow metabolism in Saccharomyces are demonstrated in this study: i) 
utilization of non-fermentable sugar, and ii) elimination of the interaction between 
phosphofructokinase and fructose 2,6-bisphosphate. Xylose utilization allowed engineered S. 
cerevisiae to dysregulate glucose-dependent repressions on cytosolic acetyl-CoA synthesis, 
ethanol re-oxidation, and oxidative phosphorylation. Restoring transcription levels of these 
metabolisms in engineered yeasts led to efficient cytosolic acetyl-CoA synthesis by 
simultaneous co-utilization of xylose and ethanol. The positive xylose effect was expanded to 
both accumulative and diffusible isoprenoids, which are synthesized from cytosolic acetyl-CoA. 
The elimination of allosteric up-regulation on phosphofructokinase and consequently upper 
glycolysis down-regulation could be achieved by mutagenesis on PFK1 and PFK2 or deletion of 
PFK26 and PFK27. Down-regulated upper glycolysis increased the availabilities of sugar 
phosphate intermediates, such as glucose 6-phosphate and fructose 6-phopsphate. Higher 
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glucose 6-phosphate availabilities led to efficient regeneration of redox cofactor NADPH, which 
is required to biosynthesize isoprenoids, fatty acids, and sterols, through oxidative pentose 
phosphate pathway and accordingly increased isoprenoid production during glucose utilization. 
Higher fructose 6-phosphate availabilities allowed engineered yeasts to synthesize more GDP-
mannose and consequently contain more cell wall mannan, a potent prebiotic oligosaccharide. 
Metabolic engineering approaches on the mannan synthetic machinery further increased cell 
wall mannan content. I demonstrated that adhesive capacities of engineered yeasts against 
pathogenic bacteria could be modulated by engineering mannan content of yeast cell wall 
fractions.  
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CHAPTER I INTRODUCTION TO YEAST METABOLIC ENGINEERING BEYOND 
ETHANOL PRODUCTION1 
 
1.1 General background 
From the ancient ages, humans have relied on a wide range of natural substances from 
foodstuff to medicinal treatments. Until recently, we have been discovering new roles of existing 
natural substances in our body or finding new natural substances as therapeutic agents for 
diseases that conventional drugs could not cure. For example, squalene, which can be 
extracted from shark liver and plant seeds, has been mainly used as moisturizer and antioxidant 
in the cosmetic and food supplement industries, but  also has capabilities to regulate cholesterol 
levels in serum (Chan et al., 1996; Zhang et al., 2002) and risks for various cancers (Murakoshi 
et al., 1992; Rao et al., 1998; Yamaguchi et al., 1985). Artemisinin was recently discovered as a 
highly effective antimalarial drug artemisinin (Ro et al., 2006). Mannan oligosaccharides can be 
found on yeast cell wall, and its role in shaping mammalian gut microbiota was demonstrated in 
the fast few years (Cuskin et al., 2015). However, many of valuable natural substances are not 
abundant in nature, and simultaneously difficult to chemically synthesize due to structural 
complexities. Extraction of the valuable substances from natural sources are, therefore, usually 
low-yielding and impractical process (Chang and Keasling, 2006). Microbial engineering 
approaches have been achieved to overcome the limitation of traditional extraction methods by 
constructing new microbial cells harboring efficient biosynthetic pathways for target substances. 
Among genetically amenable microbial host systems, yeasts, such as Saccharomyces 
cerevisiae, have advantages over bacteria regarding robustness against stresses of industrial 
                                                     
1 The content of this chapter has been submitted to Microbial Cell Factories as a review article 
and is currently under peer-review and revision. I was the first author of the paper and Yong-Su 
Jin, the director of the research, was a co-author. 
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environments, such as low pH, high osmotic pressure, and phage contamination (Auesukaree et 
al., 2009; Hong and Nielsen, 2012; Knoshaug and Zhang, 2009). 
S. cerevisiae is the best genetically characterized yeast as the first eukaryote whose 
whole genome was completely sequenced (Goffeau et al., 1996). This yeast is an indispensable 
microbial cell factory in current biotechnology and food industries, especially as an ethanol 
producer, due to its high fermentation rate and robustness to environmental stresses including 
tolerance to alcoholic products (Auesukaree et al., 2009; Hong and Nielsen, 2012; Knoshaug 
and Zhang, 2009). However, the strong dependency of S. cerevisiae on ethanol fermenting 
overflow metabolism during utilization of fermentable substrates obstructs the production of 
other than ethanol in two ways. First, it restricts glucose utilization to generate other metabolites 
than ethanol. Second, repressed regenerating metabolisms for energy or specific cofactors, 
such as NADPH, cause the inefficient production of metabolites which require higher energy 
level or the cofactor. 
 
1.2  Manipulation of fermentative metabolism of yeast on glucose 
Since glucose is the abundant and the easiest carbon source for industries to access in 
nature, metabolic engineering studies have been undertaken to increase capabilities of 
engineered yeasts producing other metabolites than ethanol from glucose, by manipulating 
yeast glucose metabolism. Specifically, S. cerevisiae and other similar Crabtree-positive yeasts 
show a rigid flux partition toward ethanol production under glucose culture conditions due to 
glucose-dependent repressions on other metabolisms. Therefore, several metabolic engineering 
studies have explored to hamper ethanol fermentation from glucose by S. cerevisiae.  
 
1.2.1 Downregulation of ethanol fermentation pathway  
 Knockout of genes involved in ethanol fermentation pathway is an effective strategy to 
reduce or eliminate metabolic flux toward ethanol. When S. cerevisiae confronts high 
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concentrations of fermentable sugars, including glucose, it metabolizes sugars to pyruvate 
through glycolysis, and subsequently converts most part of pyruvate into ethanol through two 
enzymatic reactions of pyruvate decarboxylase (PDC, EC 1.2.4.1) and alcohol dehydrogenase 
(ADH, EC 1.1.1.1) via acetaldehyde as an intermediate (Pronk et al., 1996). Therefore, 
metabolic engineering studies have concentrated on dealing with PDC and ADH to eliminate 
ethanol production of S. cerevisiae.  
As acetaldehyde is an important metabolic intermediate to synthesize cytosolic acetyl-
Coenzyme A (acetyl-CoA), knockout of ADH has been undertaken to not only minimize ethanol 
production but maintain the viability of S. cerevisiae. S. cerevisiae possesses at least six ADH 
isozymes (Adh1, Adh2, Adh3, Adh4, Adh5, Sfa1) which catalyze the interconversion between 
acetaldehyde and ethanol with the oxidation and reduction of NADH and NAD+. Although Adh1 
is the major ADH isozyme in ethanol fermentation, ADH1 deletion alone cannot eliminate 
ethanol production of S. cerevisiae, and the ethanol productivity can be recovered by 
upregulation of other ADH isozymes of which the expression is repressed before AHD1 deletion 
(Ida et al., 2012). Moreover, since the ethanol formation by ADHs is a dominant oxidizing 
process for NADH produced in glycolysis for S. cerevisiae, defective ADH activities causes 
more production of glycerol or other byproducts whose synthetic pathways also can 
regeneration NAD+ through NADH oxidation (Cordier et al., 2007; Tokuhiro et al., 2009). 
Complete deletion of six ADH isozymes and glycerol synthetic pathway allowed engineered S. 
cerevisiae to minimize both ethanol and glycerol but did not eliminate ethanol production due to 
promiscuous alcohol dehydrogenase activities (Ida et al., 2013).  
As complete elimination of catalytic activities forming ethanol from acetaldehyde in S. 
cerevisiae is hard to achieve, many metabolic engineering studies have eliminated PDC 
activities instead of ADH to fundamentally block ethanol production. S. cerevisiae possesses 
three isozymes of PDC encoded by PDC1, PDC5, and PDC6. Ethanol production in S. 
cerevisiae was eliminated by either deletion of all PDC encoding genes or double deletion of 
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PDC1 and PDC5 (Flikweert et al., 1996; Hohmann, 1991). However, PDC-deficiency severely 
inhibited the growth of yeasts in the presence of fermentable sugars at high concentrations. The 
absence of acetaldehyde synthetic pathways caused inability to synthesize cytosolic acetyl-CoA 
from sugars (Flikweert et al., 1996; Pronk et al., 1996). The lethality of PDC-deficiency in S. 
cerevisiae was alleviated by supplementing C2 compounds, such as ethanol and acetate, which 
compensate the absence of acetaldehyde as sources for cytosolic acetyl-CoA synthesis. PDC-
deficient S. cerevisiae, however, could not grow even in the presence of C2 supplements under 
high fermentable sugar concentrations due to redox imbalance by eliminating acetaldehyde, the 
substrate ADH reactions which reoxidize NADH (van Maris et al., 2004; Pronk et al., 1996). A 
directed evolution study discovered that lower expression level of hexose transporters and 
higher expression of glucose-repressible genes were peculiar characteristics of evolved PDC-
deficient S. cerevisiae strain which overcame the intolerance to high glucose concentration. The 
strain was also relieved of its independence on C2 supplement by the directed evolution, 
although its mechanism has not been clarified yet (van Maris et al., 2004). Additionally, either 
overexpression of MTH1 encoding a negative regulator of the glucose-sensing signal 
transduction or introduction of mutation delaying degradation of Mth1 successfully suppress 
growth inhibition of PDC-deficient strains under glucose culture conditions (Oud et al., 2012).   
Mutant S. cerevisiae strains lacking ethanol fermenting capabilities have potentialities to 
increase the yield of target chemicals whose biosynthesis require NADH oxidation, such as 
lactic acid is 2,3-butanediol. Lactic acid (2-hydroxypropanoic acid) is an organic acid with 
widespread applications in food, cosmetic, pharmaceutical, and polymer industries. Many 
studies have engineered yeasts with a heterologous lactate dehydrogenase (LDH, EC 1.1.1.27) 
for biological lactic acid production due to yeast can perform better than lactic acid bacteria 
under industrial and economic feasible fermentation conditions as recently reviewed (Eiteman 
and Ramalingam, 2015; Miller et al., 2011). Although furnishing a heterologous LDH allowed 
engineered S. cerevisiae to oxidize NADH by producing lactic acid, ethanol was still one of the 
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major products under fermentable sugar culture conditions (Branduardi et al., 2006; Ishida et al., 
2005; Skory, 2003). To maximize lactic acid yield, ethanol fermenting pathway, the major 
endogenous pathway oxidizing NADH, has been knocked down. Either deletion of PDC1 (Ishida 
et al., 2005; Lee et al., 2015) and double deletion of PDC1 and ADH1 (Baek et al., 2016; 
Tokuhiro et al., 2009) effectively increased lactic acid yield, but simultaneously impaired growth 
under glucose culture conditions and could not eliminate ethanol production. Ethanol production 
was more tightly regulated and lactic acid yield was close to the theoretical maximum in LDH 
expressing S. cerevisiae whose PDC1 and genes encoding the six ADH isozymes and two 
glycerol-3-phosphate dehydrogenase (EC 1.1.1.8) isozymes were deleted, but only when the 
mutant strain was used as a whole-cell catalyst at high initial cell density (Ida et al., 2013). 
The metabolic pathway converting pyruvate into 2,3-butanediol consists of acetolactate 
synthase (EC 2.2.1.6) acetolactate decarboxylase (EC 4.1.1.5), and 2,3-butanediol 
dehydrogenase (EC 1.1.1.4). As compared to lactic acid production, the 2,3-butanediol synthetic 
pathway consists of two more enzymatic reactions and requires double pyruvate molecules, but 
oxidizes the same amount of NADH. Since the 2,3-butanediol pathway is less efficient in terms 
of NADH oxidation, furnishing 2,3-butanediol pathway can neither efficiently compete with 
ethanol fermenting pathway in yeasts nor recover growth of PDC-deficient yeasts unless 
glycolytic metabolism is manipulated by rational or evolutionary engineering (Kim et al., 2013b; 
Lian et al., 2014) or heterogeneous NADH-oxidizing pathway is introduced (Kim et al., 2015a). 
Knockout of PDC and ADH is currently the most efficient strategy to minimize ethanol 
production, but it has a fundamental limitation regarding the range of possible products. The 
serial enzyme reactions of PDC and ADH are the major route to reoxidize NADH formed from 
glycolysis under high concentration of glucose or other fermentable sugars in the Crabtree 
positive yeast strains including S. cerevisiae. Therefore, yeast strains engineered based on 
PDH-ADH knockdown must be confronted with growth problems unless target molecules can be 
synthesized through redox reactions converting NADH into NAD+. Additionally, acetaldehyde, 
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the product of PDC, is converted into cytosolic acetyl-CoA, which is an indispensable metabolite 
of living organisms and a critical precursor for a wide range of valuable biochemical products. 
Therefore, peculiar phenotypes of PDC- and ADH-deficient yeast strains, slow growth, lack of 
cytosolic acetyl-CoA, and C2-dependency, can severely limit the production of growth-
dependent metabolites and all value-added chemicals derived from cytosolic acetyl-CoA.  
 
1.2.2 Introduction of heterologous acetyl-CoA synthetic pathway  
 In order to increase metabolic fluxes toward cytosolic acetyl-CoA in yeasts on glucose, 
or to supply cytosolic acetyl-CoA allowing PDC-ADH-deficient yeast strains to survive under 
glucose culture conditions, metabolic engineering studies have introduced additional 
heterologous acetyl-CoA synthetic pathways into yeasts.   
Cytosolic expression of the pyruvate dehydrogenase (PDH) complex has been 
considered as a strong strategy to increase metabolic fluxes toward cytosolic acetyl-CoA in 
yeasts without acetaldehyde generation. Eukaryotes including yeasts also utilize PDH to 
synthesize acetyl-CoA, but the complex and acetyl-CoA products are localized in mitochondria 
and cannot be natively transported out to the cytosol (Nielsen, 2014; van Rossum et al., 2016). 
Therefore, cytosolic acetyl-CoA synthesis via PDH reactions requires either relocalization of 
native mitochondrial PDH complex into cytosol or expression of heterologous cytosolic PDH 
complex. Most prokaryotic systems utilize the PDH complex in cytosolic space to convert 
pyruvate into acetyl-CoA under aerobic culture conditions. Functional expression of PDH 
complex, however, is intricate due to its complicated structure, big size, and sensitivity to high 
[NADH]/[NAD+] ratios (Koike et al., 1963; van Rossum et al., 2016; Snoep et al., 1993; Zhou et 
al., 2001). Functional expression of Enterococcus faecalis PDH complex, which shows low 
sensitivity to high [NADH]/[NAD+] ratios, allowed mutant S. cerevisiae lacking in native cytosolic 
acetyl-CoA pathway to grow under glucose conditions by compensating absence of cytosolic 
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acetyl-CoA, but it was not enough to overproduce acetyl-CoA derived molecules (Kozak et al., 
2014a). 
In contrast to PDH, pyruvate-formate lyase (PFL, EC 2.3.1.54) synthesizes acetyl-CoA 
under anaerobic culture conditions in prokaryotes. PFL splits pyruvate into acetyl-CoA and 
formate by adding coenzyme A, and the formate is oxidized to carbon dioxide by formate 
dehydrogenase (FDH, EC 1.2.1.2). A radical residue at the active site of PFL is deactivated 
during enzyme reaction but regenerated by abstraction of a hydrogen atom by the PFL-
activating enzyme (PFL-AE, EC 1.97.1.4) to preserve catalytic activities of PFL. Re-activation of 
PFL by PFL-AE requires reducing power derived from flavodoxin oxidation (Knappe et al., 
1974). The introduction of PFL and PFL-AE in S. cerevisiae exhibit accumulation formate after 
knockout of FDHs, but could not allow PDC-deficient S. cerevisiae to grow on glucose (Waks 
and Silver, 2009).  
Pyruvate-ferredoxin/flavodoxin oxidoreductase (PFOR, EC 1.2.7.1) catalyzes oxidative 
decarboxylation of pyruvate, like the reaction of PDH complex, to yield acetyl-CoA. Interestingly, 
PFOR reactions transfer electrons to ferredoxin or flavodoxin instead of NAD+. Therefore, in 
theory, PFL and PFOR reactions simultaneously and synergistically synthesize acetyl-CoA from 
pyruvate through PFL-AE reactions. However, I observed that co-overexpression of Escherichia 
coli PFL and PFL-AE together with E. coli PFOR and flavodoxin could not recover viability of 
PDC-deficient S. cerevisiae under actual glucose culture conditions with or without oxygen. This 
indicates that PFL, PFL-AE, and PFOR cannot synthesize enough cytosolic acetyl-CoA to allow 
cells to maintain their viabilities. Extremely high sensitivities to oxygen of PFL-AE and PFOR, 
iron-sulfur enzymes, could be a major drawback of this heterologous system to synthesizing 
acetyl-CoA. Additionally, different assembly machinery for iron-sulfur cluster enzymes in 
prokaryotes and eukaryotes also makes an expression of bacterial iron-sulfur enzymes difficult 
(Lill, 2009). 
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Acetylating acetaldehyde dehydrogenase (AADH, EC 1.2.1.10) is involved in the 
prokaryotic acetyl-CoA metabolism (Fig. 1.2d). Although prokaryote microorganisms mainly 
utilize AADH pathway to regenerate NAD+ from NADH derived from glycolysis by acetyl-CoA 
reduction to acetaldehyde and ethanol, part of bacterial AADHs allows engineered yeasts to 
generate acetyl-CoA from ethanol and acetaldehyde (Kozak et al., 2014b; Schadeweg and 
Boles, 2016). AADH reaction is ATP-independent and thus energetically more efficient as 
compared to native acetyl-CoA synthesis in yeasts which requires two ATP equivalents (Kozak 
et al., 2016). However, acetyl-CoA synthesis by AADH generates more NADH, which is not 
favorable in terms of redox balance during glucose utilization (Schadeweg and Boles, 2016). 
 
1.3 Production of value-added chemicals from xylose 
Microbial conversion of renewable biomass, such as plant cell walls, into biofuels and 
chemicals, is a plausible option to substitute petroleum refineries in a sustainable manner. To 
develop economic and sustainable conversion processes at an industrial scale, substrates of 
the microbial conversion must be cheap, eco-friendly, and not competing with food supply to 
avoid ethical issues (Mosier et al., 2005). Terrestrial lignocellulosic biomass, such as energy 
crops and agricultural residues, is an ideal candidate as renewable source satisfying the 
conditions. Xylose is the second most abundant monosaccharide in terrestrial lignocellulosic 
biomasses taking up 30-40% of their hydrolysates (Kim et al., 2012a; Mosier et al., 2005). Thus 
efficient xylose-fermenting microbial strains are essential for developing economically feasible 
bioconversion processes using the renewable biomasses. The most striking potential of xylose 
as a carbon source for bioconversion in yeast, however, is that xylose utilization changes 
transcriptional and physiologic characteristics of engineered yeasts in beneficial ways to 
regulate ethanol fermentation and enhance other glucose-repressible metabolisms without 
further genetic perturbations (Jin et al., 2004). 
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1.3.1  Yeast xylose metabolism 
Xylose assimilation requires the isomerization of xylose into xylulose and subsequent 
phosphorylation of xylulose into xylulose-5-phosphate which is an inlet metabolite to pentose 
phosphate pathway. Xylose-fermenting microorganisms engage two distinct pathways, the 
oxidoreductase pathway and the isomerase pathway, for conversion of xylose into xylulose (Fig. 
1.1). Most xylose-fermenting yeasts employ the oxidoreductase pathway consisting of two 
enzymatic reactions of xylose reductase (XR, EC 1.1.1.30) and xylitol dehydrogenase (XDH, EC 
1.1.1.9), which convert xylose to xylulose via xylitol. The xylose-fermenting yeast strains 
assimilate xylose mainly under aerobic conditions. XR has a dual cofactor preference with 
NADPH and NADH, whereas XDH uses only NAD+. On the other hand, the isomerase pathway 
consists of one enzymatic reaction of xylose isomerase (XI, EC 5.3.1.5), a metal-ion-dependent 
tetrameric enzyme. XI catalyzes various sugar interconversions of aldose and ketose including 
xylose and xylulose without cofactor requirement. Although most XIs have been identified from 
bacterial strains (Bhosale et al., 1996), anaerobic fungi assimilating xylose via XI, such as 
Piromyces (Harhangi et al., 2003) and Orpinomyces (Madhavan et al., 2009), have recently 
been discovered. Xylulokinase (XK, EC 2.7.1.17) catalyzes the xylulose phosphorylation to 
xylulose-5-phosphate, an intermediate of the non-oxidative pentose phosphate pathway and the 
phosphoketolase pathway. 
The pentose phosphate pathway is a universal metabolic pathway using xylulose-5-
phosphate as a metabolic intermediate. It can be divided into two distinct phases, an oxidative 
phase and a non-oxidative phase. Yeast cells metabolize xylulose-5-phosphate through the 
non-oxidative pentose phosphate pathway and form various phosphorylated sugars of three, 
four, five, six, and seven carbons which serve as intermediates of glycolysis or precursors of cell 
components such as nucleotides and amino acids (Stincone et al., 2015). The oxidative pentose 
phosphate pathway is a major route for generating NADPH which functions as a driving force for 
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the XR activity and a protection mechanism against oxidative stresses (Grant et al., 1996; 
Stincone et al., 2015) (Fig. 1.1). 
Xylulose-5-phosphate can also be metabolized through the action of phosphoketolase 
(PK, EC 4.1.2.9) in several xylose-fermenting yeasts including Candida tropicalis, Rhodotorula 
graminis, and Rhodotorula glutinis (Whitworth and Ratledge, 1977). PK cleaves xylulose-5-
phosphate to form glceraldehyde-3-phosphate and acetyl phosphate. While glyceraldehyde-3-
phosphate can be further metabolized through glycolysis and non-oxidative pentose phosphate 
pathway (Fig. 1.1), the metabolism of acetyl phosphate in these xylose-fermenting yeasts has 
not been clearly disclosed up to now. Some other eukaryotic microorganisms can convert acetyl 
phosphate into acetyl-CoA through combined reactions of acetate kinase (ACK, EC 2.7.2.1) and 
acetyl-CoA synthase (ACS, EC 6.2.1.1) or a single reaction of phosphotransacetylase (PTA, EC 
2.3.1.8) (Ingram-Smith et al., 2006) (Fig. 1.1). Recently, Meadows et al. reported that yeast 
glycerol-3-phosphate phosphatases have a promiscuous phosphatase activity on acetyl 
phosphate, resulting in acetate formation from acetyl phosphate (Meadows et al., 2016). 
Despite the abundance of xylose in nature, most yeasts, including S. cerevisiae, do not 
naturally have the ability to assimilate xylose (Jeffries, 1983; Preez and Prior, 1985). Therefore, 
various metabolic engineering approaches have been undertaken to introduce xylose metabolic 
pathways into to build economically feasible xylose utilization processes. S. cerevisiae cannot 
naturally utilize xylose, while it can assimilate xylulose through endogenous xylulokinase (XKS1) 
and pentose phosphate pathway (Richard et al., 2000). Two approaches for introducing 
optimized xylose metabolic pathways and identifying additional genetic perturbations to 
enhance xylose fermentation have been undertaken to develop efficient xylose-fermenting S. 
cerevisiae strains. 
 
1.3.2 Construction of efficient xylose-utilizing yeast with the xylose isomerase pathway 
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XI coding genes are mainly spread over bacterial genomes. Accordingly, initial attempts 
to introduce the XI pathway into S. cerevisiae employed bacterial XI genes. However, most of 
them were unsuccessful due to the difficulties in expressing bacterial XIs functionally in yeast 
(Amore et al., 1989; Moes et al., 1996; Sarthy et al., 1987). There was an approach searching 
novel XIs from soil metagenomics library based on protein sequences and activities in 
Escherichia coli, yet the identified XIs could not perform in S. cerevisiae as strong as in E. coli 
(Parachin and Gorwa-Grauslund, 2011). Discovery and application of eukaryotic XI coding 
genes from anaerobic fungi (Harhangi et al., 2003; Kuyper et al., 2003, 2005; Madhavan et al., 
2009; van Maris et al., 2007), and bacterial XI genes of Thermus thermophiles (Walfridsson et 
al., 1996), Clostridium phytofermentans (Brat et al., 2009), and Bacteroides stercoris (Ha et al., 
2011) which can be functionally expressed in S. cerevisiae enabled successful xylose 
fermentation by engineered S. cerevisiae expressing XI.  
Artificial adaptation of heterologous XIs to enhance expression and activity in S. 
cerevisiae has been conducted to improve xylose fermentation by XI expressing S. cerevisiae. 
First, codon optimization and increased gene dosages of XI expression cassette can improve XI 
activity in S. cerevisiae (Brat et al., 2009; Zhou et al., 2012). For example, Brat et al. changed 
the C. phytofermentans XI coding sequence based on the codon usage of glycolytic pathway 
genes which are highly expressed in S. cerevisiae (Wiedemann and Boles, 2008). The codon 
optimization enhanced the XI activity in S. cerevisiae, resulting in a 46% increase of specific 
growth rate on xylose (Brat et al., 2009). Laboratory evolution of a XI expressing S. cerevisiae 
led to amplification of XI expression cassette (Zhou et al., 2012). The higher copy number of the 
XI expression cassette resulted in a higher transcriptional level and consequently enhanced the 
XI enzymatic activity of the evolved S. cerevisiae compared to the parental strain containing a 
single copy of the codon-optimized XI (Zhou et al., 2012). 
Second, directed evolution is also an effective strategy to improve kinetic properties of XI 
expressed in S. cerevisiae. Lee et al. screened XI mutants which enable higher growth rate of 
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the transformant S. cerevisiae on xylose, after introducing mutated XYLA from Piromyces sp via 
three rounds of mutagenesis and growth-based screening under xylose conditions (Lee et al., 
2012b). Six amino acid substitutions (E15D, E144G, E129D, A177T, T242S, and V433I) were 
accumulated in the final mutant XYLA during the three rounds of directed evolution, and the 
essential and synergistic mutations, E15D and T242S, were further identified among the six 
mutations. Expression of the mutant XI (E15D and T242S) resulted in 8 times higher ethanol 
production and xylose consumption rate of S. cerevisiae as compared to wildtype Piromyces XI 
expression (Lee et al., 2012b). 
 
1.3.3 Construction of efficient xylose-utilizing yeast with the xylose reductase – xylitol 
dehydrogenase pathway 
Most metabolic engineering studies expressing heterologous XR-XDH pathway in S. 
cerevisiae mainly employed S. stipitis XYL1 and XYL2 genes coding for XR and XDH, 
respectively, to fill the metabolic gap between xylose and xylulose of S. cerevisiae (Ho et al., 
1998; Jin et al., 2000; Kim et al., 2013c; Kötter and Ciriacy, 1993; Walfridsson et al., 1995). 
Engineered S. cerevisiae with the XR-XDH pathway exhibited faster xylose assimilation rate 
and higher ethanol titer than engineered S. cerevisiae with the XI pathway (Karhumaa et al., 
2007; Li et al., 2016). However, the XR-XDH pathway has a drawback of the cofactor imbalance 
between the XR (mainly NADPH-dependent) and XDH (NAD+ dependent), especially under 
anaerobic conditions where NADH cannot be oxidized to NAD+ using oxygen as an electron 
acceptor. The different cofactor preferences of XR and XDH can result in NAD+ deficiency (or 
surplus NADH) which may cause the accumulation of xylitol under anaerobic conditions. As 
such, engineered yeast with the XR-XDH pathway exhibited lower ethanol yields than 
engineered yeast with the XI pathway (Karhumaa et al., 2007; Li et al., 2016). 
Dynamic flux balance analysis predicted faster xylose assimilation and higher ethanol 
titers by engineered S. cerevisiae expressing cofactor-balanced oxidoreductase pathway 
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(Ghosh et al., 2011). Also, protein engineering approaches to alter cofactor preferences of XR 
to NADH (Khoury et al., 2009; Leitgeb et al., 2005; Liang et al., 2007; Petschacher et al., 2005) 
or of XDH to NADP+ (Ehrensberger et al., 2006; Watanabe et al., 2005) through protein 
structure analysis and site-directed mutagenesis of cofactor binding pockets have been 
reported. These studies demonstrated that combinations of NADH-specific mutant XR and wild-
type XDH (Bengtsson et al., 2009; Lee et al., 2012a; Watanabe et al., 2007a) or wild-type XR 
and NADP+-specific mutant XDH (Matsushika et al., 2008; Watanabe et al., 2007b) reduce 
xylitol accumulation and improve ethanol production from xylose as compared to S. cerevisiae 
expressing the wild-type XR and XDH. 
Increasing XDH activity compared to XR activity in engineered S. cerevisiae can be an 
alternative approach to reducing xylitol accumulation. Eliasson et al. simulated xylose 
assimilation of engineered S. cerevisiae using a simplified kinetic model of XR-XDH-XK 
reactions and predicted that xylitol accumulation would be minimized when the activity ratio of 
XR/XDH is less than 0.1 (Eliasson et al., 2001). Also, engineered S. cerevisiae with low 
XR/XDH ratios led to reduced xylitol accumulation and higher ethanol yield (Eliasson et al., 
2001; Walfridsson et al., 1997a). Similarly, the efficiency of the oxidoreductase pathway can be 
improved by increasing XDH activities when XR activity levels are fixed (Jin and Jeffries, 2003; 
Kim et al., 2012b, 2013d).  
Instead of altering expression levels of XR and XDH, some studies manipulated 
endogenous oxidoreductase pathways in S. cerevisiae to change NADH/NADPH ratio so that 
XR and XDH reaction can be operated without causing redox imblance. As the oxidative 
pentose phosphate pathway is a major metabolic route for generating NADPH in S. cerevisiae 
(Fig. 1.1), knockout of related genes such as ZWF1 (glucose-6-phosphate dehydrogenase, EC 
1.1.1.49) and GND1 (6-phosphogluconate dehydrogenase, EC 1.1.1.44) substantially 
decreased cellular NADPH levels, resulting in lower XR/XDH activity ratios and lower xylitol 
yield from xylose (Jeppsson et al., 2002; Verho et al., 2003) (Fig. 1.2a). However, the impaired 
 14
XR activities due to reduced NADPH levels in the Δzwf1 and Δgnd1 mutants resulted in poor 
xylose fermentation and growth inhibtion even though xylitol accumulation reduced 
substantially. Verho et al. attempted to alleviate the negative effect of ZWF1 deletion by 
introducing a heterologous NADP+-dependent glyceraldehyde-3-phosphate dehydrogenase 
(Kluyveromyces lactis GPD1, EC 1.2.1.13). Through the combination of ZWF1 deletion and 
KlGPD1 overexpression, they achieved 48% less xylitol yield and 52% higher ethanol titer 
compared to parental S. cerevisiae expressing the XR-XDH pathway (Verho et al., 2003). 
Similarly, deletion of GDH1 encoding NADPH-dependent glutamate dehydrogenase (EC 
1.4.1.4) and the overexpression of GDH2 encoding NADH-dependent glutamate 
dehydrogenase (EC 1.4.1.2) in the ammonia utilization pathway reduced xylitol accumulation 
and increased ethanol yield during xylose fermentation (Roca et al., 2003) (Fig. 1.2b). 
Additionally, deletion of NADP+-dependent cytosolic aldehyde dehydrogenase (ALD6, EC 
1.2.1.4) improved xylose fermentation and reduced accumulation of acetate (Kim et al., 2013c; 
Lee et al., 2012a). 
Introduction of heterologous electron sink reactions capable of oxidizing surplus NADH 
was able to alleviate the cofactor imbalance and xylitol accumulation of engineered yeast with 
the oxidoreductase pathway. For example, overexpression of noxE encoding a water-forming 
NADH oxidase (EC 1.6.99.3) from Lactococcus lactis in engineered yeast with the XR-XDH 
pathway resulted in a 70% decrease of xylitol yield and 39% increase of ethanol yield through 
regenerating NAD+ from NADH with molecular oxygen as an electron acceptor (Fig. 1.2c) 
(Zhang et al., 2012). Instead of the water-forming reaction, Wei et al. constructed the acetate 
reduction pathway consisting of ACS and AADH, which converts acetyl-CoA into acetaldehyde 
(Fig. 1.2d) (Wei et al., 2013). Acetate is one of the major byproducts in lignocellulosic 
hydrolysates and it hampers fermentation and growth of yeast cells in lignocellulosic 
hydrolysates (Palmqvist and Hahn-Hägerdal, 2000). The acetate reduction pathway can exploit 
the cofactor imbalance of the XR-XDH pathway as surplus NADH is necessary to reduce acetyl-
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CoA into ethanol. The efficiency of the acetate reduction pathway depended upon expression 
levels and activities of ACS and AADH (Zhang et al., 2016). This acetate utilization strategy 
accomplished efficient xylose fermentation—less xylitol accumulation and more ethanol 
production—by utilizing the non-carbohydrate component acetate, and consequently detoxifying 
lignocellulosic hydrolysates (Wei et al., 2013; Zhang et al., 2016).  
 
1.3.4 Reconfiguration of endogenous sugar metabolism 
XK plays an important role as a linker reaction between foreign xylose assimilation 
pathways and native pentose phosphate pathway in engineered S. cerevisiae. Interestingly, S. 
cerevisiae shows a bigger gap in the growth rates between glucose and xylulose (only 6% of 
growth rate on glucose) as a sole carbon source than other yeast strains (25~130% of growth 
rate on glucose) (Richard et al., 2000), suggesting that XK activity needs to be enhanced along 
with XR-XDH (Eliasson et al., 2001; Jin et al., 2005; Johansson et al., 2001; Kim et al., 2013c; 
Lee et al., 2003; Matsushika and Sawayama, 2008; Toivari et al., 2001a) or XI (Kuyper et al., 
2005; Lee et al., 2014; Madhavan et al., 2009; Träff et al., 2001; Usher et al., 2011; Zhou et al., 
2012) to rapidly ferment xylose by engineered S. cerevisiae. Additional expression of 
endogenous XK coding gene XKS1 under the control of a strong promoter along with XYL1 and 
XYL2 improved xylose fermentation drastically (Ho et al., 1998), yet S. stipitis XK (XYL3) also 
has been adopted due to its higher activity and narrower specificity than endogenous XK (Jin et 
al., 2002, 2003a). Increase in XK activities improved xylulose fermenting capability of S. 
cerevisiae (Deng and Ho, 1990; Jin et al., 2002; Richard et al., 2000), reduced xylitol 
accumulation, and improved ethanol production in xylose-fermenting S. cerevisiae (Ho et al., 
1998; Jin et al., 2005; Johansson et al., 2001; Lee et al., 2003; Matsushika and Sawayama, 
2008; Träff et al., 2001). At the same time, however, excessive expression of XK is toxic to the 
yeast cells under xylulose (Rodriguez-Peña et al., 1998) or xylose culture conditions (Jin et al., 
2003a; Ni et al., 2007). As XK requires ATP as a substrate, overexpression of XK with 
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uncontrolled supply of xylulose can result in an imbalance of ATP consumption and ATP 
generation, and eventually ATP depletion (Jin et al., 2003a). The toxic effect of XK 
overexpression during xylose fermentation can be alleviated by the disruption of PHO13 (Ni et 
al., 2007), or moderated XK activity levels (Jin et al., 2003a; Matsushika and Sawayama, 2008). 
These studies indicate that the low XK activity of S. cerevisiae is one of the rate-limiting steps in 
the fermentation of xylulose and xylose, yet its expression level should be carefully adjusted 
with consideration of the activities of upstream and downstream metabolic pathways. 
Beyond optimization of xylose isomerization and xylulose phosphorylation, endogenous 
or S. stipitis genes coding for the enzymes involved in the non-oxidative pentose phosphate 
pathway, such as RKI1 (ribose-5-phosphate isomerase, EC 5.3.1.6), RPE1 (ribulose-5-
phosphate epimerase; EC 5.1.3.1), TKL1 (transketolase, EC 2.2.1.1), and TAL1 (transaldolase, 
EC 2.2.1.2) (Fig. 1.3), have been overexpressed. Overexpression of the enzymes involved in 
non-oxidative pentose phosphate pathway led to improved xylose assimilation rates by 
engineered S. cerevisiae expressing the XR-XDH pathway (Bera et al., 2011; Lee et al., 2012a; 
Matsushika et al., 2012a; Walfridsson et al., 1995; Xu et al., 2016) and the XI pathway 
(Karhumaa et al., 2005; Kuyper et al., 2005; Zhou et al., 2012). 
Inverse metabolic engineering studies have discovered various overexpression and 
knockout targets which are hidden limiting reactions and unknown coupled regulating factors of 
xylose utilization of S. cerevisiae. Among those targets, PHO13 has been consistently identified 
as one of the most effective deletion targets to enhance xylose-fermenting capabilities of S. 
cerevisiae (Kim et al., 2013c; Ni et al., 2007). Under xylose conditions, deletion of PHO13 
improves the cell growth rate and the ethanol productivity of engineered S. cerevisiae strains 
expressing the XR-XDH pathway (Fujitomi et al., 2012; Kim et al., 2013c; Van Vleet et al., 2008) 
or XI pathway (Lee et al., 2014) when activities of heterologous xylose pathways reach sufficient 
levels. Although physiological functions of Pho13p have not been fully disclosed yet, a recent 
study found significant changes in transcriptional patterns of S. cerevisiae after PHO13 deletion, 
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in particular, the oxidative pentose phosphate pathway, other NADPH-regenerating pathways, 
and TAL1 encoding transaldolase (Kim et al., 2015b). Transaldolase is a bottleneck of the non-
oxidative pentose phosphate pathway resulting in the accumulation of its substrate 
sedoheptulose-7-phosphate and sedoheptulose, a dead-end metabolite, during xylose 
fermentation in S. cerevisiae. Interestingly, Pho13p has a promiscuous phosphatase activity on 
sedoheptulose-7-phosphate. Thus PHO13 deletion significantly enhanced xylose fermentation 
and reduced accumulation of sedoheptulose-7-phosphate and sedoheptulose (Fig. 1.3). These 
phenotypic changes of the PHO13 deleted strain could be similarly reproduced by single 
overexpression of TAL1 (Xu et al., 2016). 
 
1.3.5 Introduction of the phosphoketolase pathway 
S. cerevisiae and other yeast strains possessing neither PK nor ACK/PTA pathways 
metabolize xylulose-5-phosphate only through pentose phosphate pathway and glycolysis. This 
oxidative glycolysis of sugars inevitably loses one carbon via carbon dioxide generation during 
conversion of pyruvate to acetaldehyde which can be further metabolized to acetate or ethanol 
(Fig. 1.4). As the combination of PK and ACK/PTA theoretically converts xylulose-5-phosphate 
to acetate or acetyl-CoA with glyceraldehyde-3-phosphate without carbon loss (Fig. 1.1 and Fi. 
1.4), many studies attempted to increase the yield of target molecules by introducing 
heterologous PK into S. cerevisiae. While the introduction of PK and ACK/PTA enhanced 
production of derivatives of cytosolic acetyl-CoA such as fatty acid ethyl esters and polyhydroxy 
butyrate under glucose culture conditions (de Jong et al., 2014; Kocharin et al., 2013), the 
performance of PK under xylose culture conditions is still ambiguous. Sonderegger et al. 
attempted to increase ethanol yield on xylose through the carbon conserving route of PK, PTA, 
and AADH (Fig. 1.4). Overexpression of PK in S. cerevisiae, however, resulted in significant 
accumulation of acetate under xylose culture conditions, instead of ethanol. Interestingly, they 
argued that S. cerevisiae showed marginal, yet reliable endogenous activities of PK. 
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Overexpression of PTA and AADH without furnishing heterologous PK resulted in 25% increase 
in ethanol yield on xylose (Sonderegger et al., 2004a). Given the potential of the carbon 
conserving nature of the PK pathways, in depth investigation of the innate PK pathway in S. 
cerevisiae will be necessary. 
 
1.3.6 Production of advanced biofuels and chemicals from xylose 
Despite numerous metabolic engineering efforts, S. cerevisiae still cannot ferment 
xylose to ethanol as efficiently as glucose. During glucose utilization, S. cerevisiae efficiently 
ferments glucose to ethanol and carbon dioxide by repressing unnecessary metabolic pathways 
except for alcoholic fermentation regardless of oxygen presence (Pfeiffer and Morley, 2014). On 
the contrary, xylose utilization by engineered S. cerevisiae results in lower metabolic activities of 
the glycolytic pathway (Matsushika et al., 2013; Pitkänen et al., 2003; Wahlbom et al., 2001), 
and higher expression of genes involved in non-fermentative metabolism through dysregulation 
of glucose-dependent repression that causes redirection of metabolic fluxes toward byproducts 
from ethanol production (Alff-Tuomala et al., 2016; Jin et al., 2004; Matsushika et al., 2014; 
Salusjärvi et al., 2008). These genetic and metabolic characteristics of engineered S. cerevisiae 
grown on xylose are obstacles to the efficient and rapid production of ethanol from xylose. 
However, at the same time, the metabolic pattern of xylose fermentation might be advantageous 
for producing advanced biofuels and chemicals as synthetic pathways to produce target 
molecules can overturn the innate metabolic preference to produce ethanol by S. cerevisiae. 
The following parts introduce recent studies reporting the beneficial effects of xylose utilization 
on the production of biofuels and chemicals instead of ethanol by engineered S. cerevisiae. 
1-Hexadecanol, also known as cetyl alcohol and palmityl alcohol, has been used as an 
emulsifier and a lubricant in various industrial fields, and considered as a potential advanced 
biofuel. Guo et al. compared productivities of 1-hexadecanol in engineered S. cerevisiae under 
xylose and glucose culture conditions (Guo et al., 2016). They previously produced 1-
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hexadecanol in engineered S. cerevisiae by the introduction of fatty acyl-CoA reductase, and 
further improved its productivity through overexpressing acetyl-CoA carboxylase (ACC1), 
knocking out a negative regulator of phospholipid metabolism, and introducing heterologous 
cytosolic acetyl-CoA synthetic enzyme, ATP-citrate lyase (Feng et al., 2015). The introduction of 
the optimized XR-XDH-XK expression system and subsequent laboratory evolution on xylose 
allowed the previous engineered S. cerevisiae to produce 1-hexadenanol from xylose. The 
resulting xylose-utilizaing engineered S. cerevisiae showed a much higher yield of 1-
hexadecanol in both batch (0.10 g/g) and fed-batch fermentation (0.08 g/g) from xylose as 
compared to glucose (0.03 and <0.01 g/g, respectively) (Feng et al., 2015; Guo et al., 2016). 
Three peculiar genetic and physiological characteristics of xylose metabolism are speculated to 
exhibit the positive effect of xylose on fatty alcohol synthesis in S. cerevisiae. First, cytosolic 
acetyl-CoA, the core intermediate of acyl-CoA synthetic metabolism, could be more efficiently 
produced under xylose culture conditions compared to glucose, due to dysregulation of glucose-
dependent repression on genes related to ethanol re-assimilation (ADH2) and cytosolic acetyl-
CoA synthesis (ALD3, ALD6, ACS1) (Jin et al., 2004; Salusjärvi et al., 2008) (Fig. 1.5). Second, 
upregulation of genes encoding enzymes in the tricarboxylic acid cycle or respiratory enzymes 
in mitochondria (Jin et al., 2004; Salusjärvi et al., 2008) probably improved ATP and citrate 
generation and consequently enhanced cytosolic acetyl-CoA synthesis via endogenous ACS 
and heterologous ATP citrate lyase (Fig. 1.5). Lastly, as extracellular xylose cannot sufficiently 
interact with Snf1p (Brink et al., 2016), a sensor protein that downregulates the expression of 
ACC1 and upregulates -oxidation (Feng et al., 2015), xylose culture could prevent inhibition of 
fatty acid synthesis and degradation of acyl-CoA. 
Instead of genetic perturbations for diminishing ethanol production, Turner et al. 
introduced LDH into an efficient xylose-fermenting S. cerevisiae. They demonstrated that the 
engineered S. cerevisiae efficiently produces lactic acid without detectable ethanol 
accumulation on xylose (YLactate/Xylose = 0.69 g/g xylose, YEthanol/Xylose < 0.01 g/g xylose), while the 
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engineered yeast produced lactic acid and ethanol simultaneously at 2:3 ratios on glucose 
(YLactate/Xylose = 0.22 g/g glucose, YEthanol/Xylose = 0.31 g/g glucose) (Turner et al., 2015). The 
weaker metabolic activity of glycolysis on xylose (Matsushika et al., 2013; Pitkänen et al., 2003; 
Wahlbom et al., 2001) is a probable interpretation of this phenomenon. LDH competes with 
PDC for pyruvate which is the final product of glycolysis as well as the branch point metabolite 
between lactate and ethanol pathways. As LDH has smaller KM value than PDC (Turner et al., 
2015), the inefficient glycolytic metabolism under xylose culture conditions would allow LDH to 
direct more metabolic flux from pyruvate than endogenous PDC. Additionally, the expression 
level of JEN1, a lactate-proton symporter coding gene, is upregulated under xylose through 
dysregulation of glucose-dependent repression (Jin et al., 2004). Efficient transporting lactic 
acid to the outside of yeast cells via Jen1p increases productivity and yield of lactic acid as LDH 
reaction is reversible and allosterically inhibited by lactate (Branduardi et al., 2006) (Fig. 1.5). 
 
1.3.7  Concluding remarks and future perspectives  
Bioethanol production in Saccharomyces cerevisiae is the most developed and 
optimized biological process in both biochemical and food industries. However, production of 
more functional and value-added molecules than ethanol in S. cerevisiae is also anticipated to 
enhance. The rigid fermentative metabolic flux from glucose to ethanol in the Crabtree-positive 
yeast S. cerevisiae must be firstly regulated to allow the yeast to efficiently produce other 
metabolites than ethanol. Knockout of ethanol production pathway consisting of PDC and ADH 
is the easiest but the clearest strategy to minimize ethanol production. PDC-ADH knockout 
caused two lethal problems, redox imbalance and lack of cytosolic acetyl-CoA. Both problems 
could be alleviated by evolutionary engineering and introduction of heterologous pathways 
producing target molecules and oxidizing NADH. However, metabolites generated via non-redox 
metabolism or acetyl-CoA synthetic pathway could not be applied to the PDC-ADH knockout 
strategy.  
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Acetyl-CoA is an important precursor for many valuable biochemical products. However, 
there are hurdles impeding ample biosynthesis of acetyl-CoA-derived products in S. cerevisiae. 
First, acetyl-CoA synthesis in S. cerevisiae is compartmentalized in four different cellular 
spaces: mitochondria, cytosol, peroxisome, and nucleus. While many valuable acetyl-CoA 
derived chemicals, such as isoprenoids, sterols, polyketides, polyphenols, and waxes, are 
synthesized in the cytosol, cytosolic acetyl-CoA synthesis in yeast is limited. Second, the 
cytosolic acetyl-CoA synthetic pathway shares acetaldehyde as an intermediate but 
acetaldehyde is drained by the ethanol producing pathway. Third, the native ACS reaction of S. 
cerevisiae is energetically expensive (Nielsen, 2014). Although previous metabolic engineering 
studies have introduced various heterologous cytosolic acetyl-CoA synthetic pathways in PDC-
deficient yeasts to minimize ethanol production and maximize cytosolic acetyl-CoA production, 
all heterologous pathway could not allow the mutant yeasts to overproduce acetyl-CoA 
derivatives. 
As distinctive features of S. cerevisiae xylose metabolism mitigate the three hurdles, I 
speculated that the positive effect of xylose utilization on the fatty alcohol production would be 
extended to the biosynthesis of other value-added molecules deriving from cytosolic acetyl-CoA. 
In-depth studies about the PK-ACK/PTA pathway (Fig. 1.1)—a carbon conserving cytosolic 
acetyl-CoA synthetic metabolism—would be necessary to further enhance the yield of cytosolic 
acetyl-CoA derivatives under xylose conditions. 
In the same manner, engineered S. cerevisiae would exhibit a higher yield of not only 
lactic acid but also other molecule derived from pyruvate or other glycolysis intermediates. 
However, prior studies reported contrary results to this expectation. No meaningful 
improvements in the production of 2,3-butanediol (Kim et al., 2014) and isobutanol (Brat and 
Boles, 2013) which are derived from pyruvate have been reported under xylose conditions. A 
notable difference between the enhanced lactic acid production and the latter ineffectual 
production of 2,3-butanediol and isobutanol is the order of metabolic engineering efforts. 
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Namely, for the production of 2,3-butanediol and isobutanol, xylose pathways were introduced 
after optimizing the production pathway from glucose, while the lactic acid study furnished LDH 
into a host strain which had already optimized for xylose fermentation. 
To produce 2,3-butanediol from xylose by engineered yeast, the XR-XDH pathway was 
introduced to a PDC-deficient S. cerevisiae harboring a mutation in MTH1 and a heterologous 
2,3-butanediol synthetic pathway (Kim et al., 2013b, 2014). The 2,3-butanediol synthetic 
pathway regenerates a half amount of NAD+ regenerated from the LDH reaction which can 
regenerate an equivalent amount of NAD+ as compared to PDC-ADH reactions. This insufficient 
NAD+ regeneration from 2,3-butanediol production and surplus NADH derived from the XR-XDH 
pathway induce NADH oxidation via glycerol synthesis during xylose conversion to 2,3-
butanediol and consequently resulted in lower 2,3-butanediol yields compared to that from 
glucose (Fig. 1.5). Considering redox imbalances of xylose pathway and 2,3-butanediol 
pathway, introduction of the XI pathway, which does not require cofactors, would be more 
appropriate perturbation to observe the positive xylose effect on 2,3-butanetiol production 
Similarly, the isobutanol study also introduced the XI pathway into an existing S. 
cerevisiae engineered for efficient isobutanol production from glucose through re-localization of 
mitochondrial Ilv2p (acetolactate synthase), Ilv5p (keto-acid reductoisomerase, EC 1.1.1.86), 
and Ilv3p (dihydroxyacid dehydratase, EC 4.2.1.9) to cytosol (Brat et al., 2012) (Fig. 1.5). 
Although the engineered S. cerevisiae successfully overcame the loss of mitochondrial function 
and increased isobutanol production on glucose, the re-localization of mitochondrial pathway 
was not an appropriate strategy on xylose as utilization of non-fermentable sugars dysregulates 
glucose-dependent repression on the development of mitochondria and induces its metabolism 
(DeRisi et al., 1997; Egner et al., 2002). In that respect, I can assume that reverse localization 
of cytosolic pathway into mitochondria (Avalos et al., 2013) is a proper strategy to improve 
isobutanol production from xylose (Fig. 1.5).  
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Inadequate optimization of xylose pathways could also be a considerable cause of the 
inefficient production of the 2,3-butanediol and isobutanol from xylose as compared to glucose. 
Especially, the MTH1 mutation (A81P) alleviated the toxic effects on cell growth by PDC 
knockout via decreased sugar influx during glucose fermentation (Kim et al., 2013b), yet higher 
MTH1 expression levels under xylose conditions (Jin et al., 2004) could additionally reduce 
xylose influx and further decrease 2,3-butanediol productivity as compared to glucose. 
 I can come to a conclusion that xylose might serve better than glucose as a substrate for 
producing advanced biofuels and chemicals in S. cerevisiae, such as molecules derived from 
cytosolic acetyl-CoA or pyruvate, yet only through appropriate metabolic engineering 
approaches. First of all, optimization of the xylose metabolic pathway is pre-requisite for efficient 
conversion of xylose to target molecules. To maximize the positive effect of xylose, synthetic 
pathways for target molecules, additional genetic perturbations, and culture conditions should 
be carefully determined with consideration of distinctive features of S. cerevisiae xylose 
metabolism in redox status, metabolic fluxes, and transcriptional patterns, instead of furnishing 
xylose assimilation pathways into existing systems. 
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1.4 Figures 
 
 
Fig. 1.1 Overview of xylose assimilation pathways in yeasts. Red items indicate yeast metabolic 
pathways which have been introduced into S. cerevisiae. 6-PGL, 6-phosphoglucono-1,5-
lactone; 6-PG, 6-phosphogluconate; GA-3-P, glyceraldehyde-3-phosphate. 
 
 
 
 
 
 25
 
Fig. 1.2 Control of redox balance by manipulating endogenous metabolism (a, b) and furnishing 
heterologous electron sink reactions (c, d). Endogenous NADPH regenerating enzymes of the 
oxidative pentose phosphate pathway (a) and the ammonia utilization pathway were deleted to 
reduce XR activity and accordingly develop a lower XR/XDH activity ratio. Surplus NADH was 
alleviated via NADH oxidase reaction (a) or utilized as a driving force of acetate reduction 
pathway consisting of acetyl-CoA synthase (ACS) and acetylating acetaldehyde dehydrogenase 
(AADH) (b). Gene nomenclature: ZWF1, glucose-6-phsophate dehydrogenase; GND1, 6-
phosphogluconate dehydrogenase; GDH1, NADPH-dependent glutamate dehydrogenase; 
GDH2, NADH-dependent glutamate dehydrogenase; noxE, NADH oxidase from L. lactis; adhE, 
AADH from Escherichia coli. 
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Fig. 1.3 Schematics of the non-oxidative pentose phosphate pathway. While other intermediates 
can be shunted to glycolysis, sedoheptulose-7-phosphate is converted into a dead-end 
metabolite sedoheptulose by promiscuous phosphatase activity of Pho13p. The expression of 
TAL1 is indirectly regulated by PHO13. Gene nomenclature: RKI1, ribose-5-phosphate 
isomerase; RPE1, ribulose-5-phosphate epimerase; TKL1, transketolase; TAL1, transaldolase. 
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Fig. 1.4 Comparison of a synthetic PK-PTA-AADH pathway (left, blue) and native metabolism of 
xylulose-5-phosphate (right) via pentose phosphate pathway and glycolysis. The synthetic 
pathway is more carbon-conserving in ethanol production, compared to native metabolism, due 
to its absence of carbon losing enzymatic reactions, such as pyruvate decarboxylase. The 
dotted arrow indicates promiscuous acetyl phosphate phosphatase activities of S. cerevisiae. 
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Fig 1.5 Schematic comparison between glucose (orange) and xylose (blue) metabolisms in 
engineered S. cerevisiae. Colored distinction of arrows indicates which sugar induce each 
metabolic pathway to be predominant. Xylose-derived weaker glycolysis metabolic activity and 
dysregulation of glucose repressions on cytosolic acetyl-coA synthetic pathway and 
mitochondrial development (green) allowed S. cerevisiae to more efficiently produce derivatives 
of pyruvate and cytosolic acetyl-CoA. 
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CHAPTER II ADVANTAGES OF XYLOSE UTILIZATION FOR PRODUCTION OF ACETYL-
COA DERIVATIVES IN ENGINEERED YEAST2 
 
2.1  Introduction 
Isoprenoids comprise a large class of natural organic compounds consisting of (2-
methyl-1,3-butadiene) unit molecules. Isoprenoids play a role in a variety of biochemical and 
physiological functions in living organisms such as membrane fluidity control (sterols), 
intracellular signaling (prenylation), aerobic respiration and photosynthesis (quinones) (Chang 
and Keasling, 2006; Ro et al., 2008), and also participate in interactions among plants and 
animals as repellents to antagonists or attractants for mutualists (Gershenzon and Dudareva, 
2007). From an industrial point of view, isoprenoids are being commercialized as flavors, 
fragrances, nutraceuticals, and pharmaceuticals (Paradise et al., 2008). For example, squalene 
is a 30-carbon isoprenoid (triterpene) that mainly has applications in the cosmetic and food 
supplement industries. It is directly or indirectly linked to the capacities to reduce serum 
cholesterol level (Chan et al., 1996; Zhang et al., 2002) and decrease risks for various cancers 
(Murakoshi et al., 1992; Rao et al., 1998; Yamaguchi et al., 1985). Amorphadiene, a plant 
derived 15-carbon isoprenoid (sesquiterpene), is a precursor of antimalarial drug artemisinin 
(Ro et al., 2006) (Fig. 2.1). 
Since isoprenoids are low-abundant secondary metabolites, isoprenoid extraction from 
natural sources is usually low-yielding and inefficient, and accordingly requires considerable 
consumption of natural sources (Chang and Keasling, 2006). To circumvent the limitations of 
the traditional extraction processes, significant metabolic engineering efforts have been made to 
                                                     
2 The content of this chapter has been submitted for peer-review to Biotechnology and 
Bioengineering. I was the first author of the paper and Soo Rin Kim, Haiqing Xu, Guo-Chang 
Zhang, Heejin Kim, Stephan Lane, and Yong-Su Jin were co-authors. I performed the research 
with help from the co-authors and Dr. Yong-Su was the director of the research. 
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achieve overproduction of isoprenoids using microorganisms such as Saccharomyces 
cerevisiae.  Previous studies of isoprenoid production in S. cerevisiae have focused on genetic 
modifications of the MEV pathway to increase the intracellular pool of precursor of target 
isoprenoids. Among the enzymes in the MEV pathway, HMG-CoA reductase, a major rate-
limiting step of eukaryote sterol synthesis, has been recognized as an essential manipulation 
target for enhancing the flux of the MEV pathway (Hampton and Rine, 1994). In S. cerevisiae, 
two genes (HMG1 and HMG2) coding for HMG-CoA reductase isozymes are controlled by 
regulation at translational and post-translational levels (Burg and Espenshade, 2011). 
Overexpression of a truncated HMG1 (tHMG1), lacking a regulatory domain, is currently the 
most effective strategy for isoprenoid overproduction (Donald et al., 1997). Overexpression of 
the tHMG1 resulted in increased accumulation of squalene without altering the cellular 
ergosterol content due to presence of another regulatory step after squalene (Donald et al., 
1997; Polakowski et al., 1998). In addition to the manipulation of HMG1, up-regulation of genes 
coding for enzymes in the MEV pathway has been reported to improve isoprenoid production in 
S. cerevisiae. For example, direct up-regulation of the MEV pathway related genes such as 
HMG2, ERG8, ERG9, ERG10, ERG12, ERG13, MVD1 (ERG19), IDI1, and ERG20 using 
inducible or strong constitutive promoters (Dai et al., 2013; Mantzouridou and Tsimidou, 2010; 
Yuan and Ching, 2014), indirect up-regulation through expression of an activated mutant allele 
of a sterol synthesis transcriptional activator UPC2-1 (Davies et al., 2005; Ro et al., 2006), or 
combination of direct and indirect up-regulations (Paddon et al., 2013; Westfall et al., 2012) 
have been attempted to increase the production of isoprenoids.  
Despite these genetic perturbations for increasing metabolic flux to target isoprenoids, 
ethanol still remains as a major product of S. cerevisiae due to a rigid metabolic flux toward 
ethanol production during glucose utilization (Pfeiffer and Morley, 2014). In addition, utilizing 
glucose as a carbon source for producing fuels and chemicals may present a food security 
issue as glucose is derived from edible sources for human and animals. As such, we have 
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undertaken a metabolic engineering approach to enable efficient production of isoprenoids from 
xylose, a non-edible sugar and the second most abundant sugar in nature. As S. cerevisiae 
cannot naturally use xylose, heterologous genes coding for xylose reductase (XR), xylitol 
dehydrogenase (XDH), and xylulokinase (XK) needs to be optimally expressed in S. cerevisiae 
to enable xylose utilization (Jin et al., 2003; Kim et al., 2013; Toivari et al., 2001; Walfridsson et 
al., 1997) (Fig. 2.1). To improve xylose fermentation by engineered S. cerevisiae, genes coding 
for enzymes in the pentose phosphate pathway have been overexpressed (Bengtsson et al., 
2008; Jin et al., 2005; Matsushika et al., 2012b; Wahlbom et al., 2003). In particular, 
transaldolase (TAL1) might be the most significant rate-limiting step as the xylose consumption 
rates of engineered yeasts were proportional to the expression level of TAL1 increases (Xu et 
al., 2016). Importantly, xylose utilization elicited different physiologic characteristics of 
engineered S. cerevisiae as compared to glucose utilization. While glucose metabolism of S. 
cerevisiae is entirely fermentative, i.e. strong repression of respiratory metabolism by glucose 
even in the presence of oxygen (Pfeiffer and Morley, 2014), such repression on respiratory 
metabolism is often delayed, or alleviated during xylose metabolism even under anaerobic 
conditions (Alff-Tuomala et al., 2016; Matsushika et al., 2014). Therefore, we reasoned that the 
use of xylose might enhance the production of isoprenoids by reducing fermentative metabolism 
and increasing oxidative metabolism. 
 The aim of this study was to investigate the capability of xylose as a carbon source to 
produce isoprenoids in S. cerevisiae via genetic and phenotypic studies. From RNA sequencing 
(RNA-seq) data, we discovered beneficial transcriptional patterns in the cells metabolizing 
xylose with respect to the supply of cytosolic acetyl-CoA as compared to the cells metabolizing 
glucose. To demonstrate enhanced production of isoprenoid from xylose, we chose squalene 
and amorphadiene as model isoprenoids. From the comparison of squalene and amorphadiene 
production patterns from glucose and xylose by engineered yeast strains, we conclude that 
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utilization of xylose as a carbon source is a promising strategy for the overproduction of acetyl-
CoA derived chemicals in yeasts. 
 
2.2 Materials and methods 
 
2.2.1 Strains and media for gene cloning 
E. coli Top10 strain was used for the construction of plasmids. After transformation, E. 
coli was grown in the Luria Bertani medium (5 g/L of yeast extract, 10 g/L of Tryptone, and 5 g/L 
of NaCl), under aerobic conditions, at 37˚C with 100 μg/mL of ampicillin. Xylose-fermenting S. 
cerevisiae SR7, which contains overexpression cassettes for xylose metabolizing pathways 
(Kim et al., 2013e), was used as a starting strain for the construction of squalene and 
amorphadiene producing strain. RNA expression patterns on glucose and xylose were 
determined through RNA-seq which was conducted on an Illumina HiSeq 2000 system at the W. 
M. Keck Center for Comparative and Functional Genomics at the University of Illinois at Urbana-
Champaign. 
The Yeast Peptone (YP) medium (10 g/L of yeast extract and 20 g/L of peptone) 
containing 20 g/L of glucose (YPD) was used for routine cultivation of S. cerevisiae and 
CRISPR-Cas9 based genome editing experiments. 100 μg/mL of nourseothricin, 300 μg/mL of 
geneticin, and 200 μg/mL of hygromycin B were added if required for the selection of 
transformants. The notations of selection media with antibiotics are as follows. YPDN 
represents a YPD medium containing nourseothricin, YPDNG represents a YPD medium 
containing nourseothricin and geneticin, and YPDNH represents a YPD medium containing 
nourseothricin and hygromycin B. 
 
2.2.2  Plasmid construction 
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A description of plasmids, primers, and guide RNA (gRNA) target sequences used in this 
study are summarized in Table 2.2, Table 2.3, and Table 2.4, respectively. A previous Cas9-
NAT plasmid (Addgene plasmid #64329) (Zhang et al., 2014) was adopted for the expression of 
Cas9 nuclease in yeast. gRNA expression cassettes for intergenic sites on chromosome XV 
(CS5), VII (CS6), XVI (CS8), and a gRNA expression cassette targeting ERG1 promoter region 
(RC4) were constructed by replacing the target sequence regions of previous gRNA cassettes 
(Zhang et al., 2014, 2016). The target sequences (CS5, CS6, CS8, and RC4) for genome 
editing were amplified through PCR using gRNA-U and gRNA-D primers and inserted between 
SacI and BamHI sites of the 2-micron plasmids pRS42K and pRS42H (EUROSCARF). The 2-
micron plasmids with TDH3 promoter (PTDH3) and CYC1 terminator (TCYC1) (Mumberg et al., 
1995) were used as a backbone for the construction of constitutive expression cassettes of 
truncated HMG-CoA reductase 1 (tHMG1) and acetyl-CoA C-acetyltransferase (ERG10). 
pRS425ADS (Addgene plasmid #20119) harboring the codon optimized Artemisia annua 
amorpha-4,11-diene synthase gene (ADS) (Ro et al., 2006) was a gift from Jay Keasling. 
Another 2-micron plasmid pRS426CCW was used as a backbone to construct constitutive 
expression cassette of ADS. 
To obtain a tHMG1, 1,584 bp DNA from 5’ end of HMG1 was deleted, and a new start 
codon was added during PCR amplification. The amplified tHMG1 was introduced between 
PTDH3 and TCYC1 of pRS425GPD by using SpeI and XhoI. The ERG10 expression cassette 
bracketed by PTDH3 and TCYC1 was previously constructed based on pRS423GPD using BamHI 
and XhoI (Yun et al., 2015). tHMG1 and ERG10 were cloned from S. cerevisiae D452-2 
genomic DNA. ADS was amplified from pRS425ADS (Ro et al., 2006) and inserted between 
CCW12 promoter (PCCW12) and TCYC1 of pRS426CCW by using SpeI and HindIII. Q5 high-fidelity 
DNA polymerase (New England Biolab, Ipswich, MA, United States) was used for CS5, CS6, 
tHMG1, ERG10, and ADS cloning. 
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2.2.3  Strain construction using CRISPR-Cas9 system 
To improve xylose assimilation of the SR7 strain, TAL1 expression was maximized by 
the insertion of PCCW12 in front of the TAL1 open reading frame in the SR7 genome (Xu et al., 
2016). The resulting strain was named HX4. Before introducing further genetic modifications, 
the Cas9-NAT plasmid was transformed into the HX4. The Cas9 expressing HX4 was selected 
from YPDN plate. 
Double-stranded donor DNA (dDNA) harboring tHMG1 expression cassette was 
amplified using a primer set of dDNA-CS5, and dDNAs for ERG10 and ADS expression 
cassette were amplified using primer sets of dDNA-CS6 and dDNA-CS8 (Table 2.3), 
respectively. dDNA products were purified and concentrated by ethanol acetate precipitation to 
secure high concentration after PCR amplification. gRNA plasmid pRS42K-CS5 and tHMG1 
expression cassette dDNA were transformed into the Cas9 expressing HX4 strain to construct 
tHMG1 overexpressing strain HX4H. The HX4H strain was selected on YPDNG plate. pRS42H-
CS6 and ERG10 expression cassette dDNA were transformed into the Cas9 expressing HX4 
and the HX4H strains to construct ERG10 overexpressing and tHMG1-ERG10 co-
overexpressing strains (HX4E and HX4HE). The HX4E and HX4HE strains were selected using 
YPDNH plate. HX4HE was cultured in and spread on YPDN for curing previous gRNA plasmids 
pRS42K-CS5 and pRS42H-CS6, which could stay in the HX4HE strains after tHMG1 and 
ERG10 integrations by Cas9 genome editing. Cured HX4HE strains were screened via replica 
plating on YPDNG and YPDNH plates.  
Co-transformation of pRS42K-CS8 and dDNA of ADS overexpression cassette was 
conducted with the cured HX4HE strain, and an ADS overexpressing HX4HE (HX4HEA) strain 
was screened from YPDNG plate. Promoter regions of ERG1 and SYH1 were amplified from 
genomic DNA of S. cerevisiae D452-2 using primer sets of dDNA-PERG1 and dDNA-PSYH1, 
respectively, as dDNAs for substitution of farnesyl-diphosphate farnesyl transferase (squalene 
synthase, ERG9) promoter. A Cas9 expressing HX4HEA strain was transformed with gRNA 
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plasmid pRS42H-RC4 and each dDNAs. ERG9 promoter substituted HX4HEA strains were 
selected from YPDNH plate. 
The lithium acetate/single strand carrier DNA/polyethylene glycol method (Gietz and 
Schiestl, 2007) was used to introduce Cas9-NAT, gRNA expression vectors, and donor DNA 
fragments into yeasts. Screened colonies on selection plates were confirmed by colony PCR 
and sequencing the PCR products using confirmation primers (Table 2.3). Phusion High-Fidelity 
PCR Master Mix with HF buffer (New England Biolabs) was used for dDNA amplification, and 
Q5 high-fidelity DNA polymerase (New England Biolabs) was used for colony PCR.  
 
2.2.4  Yeast culture for isoprenoid production 
To compare squalene production by engineered yeast strains on glucose and xylose, 
engineered strains were regenerated in 5 mL YPD medium, washed, and collected. Harvested 
cell pellets were transferred into 5 mL of YPD or YPX (YP medium containing 20 g/L of xylose) 
medium and grown as pre-cultures for glucose and xylose main cultures, respectively. Pre-
cultured cells were harvested, washed with sterilized water, and inoculated into main culture 
medium at initial optical density 0.1. Main cultures were performed with 50 mL of YP medium 
containing 40 g/L of glucose or xylose in 250 mL baffled flasks at 30C, 300 rpm. Cultures were 
conducted until xylose was depleted, and cell pellets were harvested at glucose and xylose 
depletion time point for squalene analysis. 
For xylose fed-batch culture, the engineered strain was cultured in 100 mL of the YP 
medium containing 40 g/L of xylose for 30 hours at 30°C and 300 rpm with baffled flasks as a 
pre-culture. Cells were harvested at 8,000g and 4˚C for 5 min and washed with sterilized water 
before inoculation. Fed-batch culture was conducted in BioFlo & CelliGen 310 fermentor (New 
Brunswick Scientific-Eppendorf, Enfield, CT, United States) using the modified Verduyn medium 
(van Hoek et al., 2000) containing 15 g/L of (NH4)2SO4, 8 g/L of KH2PO4, 3 g/L of MgSO4, 10 mL 
of the trace element solution and 12 mL of the vitamin solution. The trace element solution 
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contained 15 g/L of EDTA, 5.75 g/L of ZnSO4, 0.32 g/L of MnCl2, 0.50 g/L of  CuSO4, 0.47 g/L of 
CoCl2, 0.48 g/L of Na2MoO4, 2.9 g/L of CaCl2, and 2.8 g/L of FeSO4. The vitamin solution 
contained 0.05 g/L of biotin, 1 g/L of calcium pantothenate, 1 g/L of nicotinic acid, 25 g/L of 
myoinositol, 1 g/L of thiamine hydrochloride, 1 g/L of pyridoxol hydrochloride, and 0.2 g/L of p-
aminobenzoic acid. Initial xylose concentration was 80 g/L, and additional xylose was added to 
bioreactor up to 80 g/L upon its depletion. pH was automatically controlled at 5.8 by adding 3N 
NaOH solution. 
To compare the production of amorphadiene by engineered yeast strains on glucose 
and xylose, engineered yeasts were cultured in 250 mL baffled flasks and 50 mL of synthetic 
complete (SC) medium (MP Biomedicals, Santa Ana, CA) following previous reports (Paradise 
et al., 2008; Yuan and Ching, 2014, 2015). 40 g/L of glucose or xylose were used to determine 
the carbon source effect. The medium was buffered by 50 mM potassium hydrogen phthalate 
buffer at pH 5.5. 5 mL of dodecane was added into each culture flasks after filtration using 
Millex®-MP 0.22μm filter unit (EMD Millipore, Billerica, MA, United States) to trap volatile 
amorphadiene (Asadollahi et al., 2008). 
 
2.2.5  Enzyme assays 
To measure HMG-CoA reductase and acetyl-CoA C-acetyltransferase activities in each 
engineered strain, cells were harvested at the middle of exponential growth phase. Cell cultures 
at 12 hour for glucose cultures and 24 hour for xylose cultures were centrifuged at 8,000g and 
4˚C, for 10 min. Crude enzyme was extracted from the harvested cells by following a previously 
described method (Çağlayan and Wilson, 2014). After washing with distilled water and 
recollecting, harvested samples were vigorously vortexed with 1 mL of yeast lysis buffer (25 mM 
Tris-HCl, 1mM EDTA, 100 mM NaCl, 10 mM β-mercaptoethanol, pH 7.5) with protease inhibitor 
(cOmplete Protease Inhibitor Cocktail, Roche, Basel, Switzerland), and 0.2 g of glass beads for 
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15 minutes. After centrifugation at 25,200g and 4˚C for 10 min, the supernatant was collected 
and used as a crude enzyme. 
HMG-CoA Reductase Assay Kit (Sigma-Aldrich, St. Louis, MO, USA) was used for 
HMG-CoA reductase activity assay through measuring NADPH concentration. The decrease of 
NADPH concentration was measured at 340 nm and the NADPH molar extinction coefficient 
6.22 mM-1cm-1 was used for calculation. One unit of HMG-CoA reductase activity was defined 
as the amount of enzyme required to convert 1 μmol of NADPH to NADP+ per minute at 30˚C. 
Acetyl-CoA C-acetyltransferase activity was determined by measuring the decrease of 
acetoacetyl-CoA concentration in the presence of acetoacetyl-CoA and CoA, in the thiolysis 
direction (Wiesenborn et al., 1988). To the reaction mixture containing 100 mM Tris-HCl buffer 
(pH 8.0), 10 mM MgCl2, 1 mM 1,4-dithiothreitol, 0.2 mM CoA, and 50 µM acetoacetyl-CoA, the 
crude enzyme solution was added to initiate enzyme reaction. The decrease of acetoacetyl-CoA 
was measured at 303 nm and the acetoacetyl-CoA molar extinction coefficient 14 mM-1cm-1 was 
used for calculation (Inui et al., 2008). One unit of acetyl-CoA C-acetyltransferase activity was 
defined as the amount of enzyme required for the thiolytic cleavage of 1 µmol of acetoacetyl-
CoA per minute at 30˚C. 
All activity assays were conducted using Synergy 2 microplate reader (Biotek, Winooski, 
VT, United States) with 96-well plate, in 200 μL reaction volume at 30˚C. Activity values were 
normalized by protein concentration of the enzyme reaction mixture. The protein concentration 
was measured through PierceTM BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, 
MA, United States). 
 
2.2.6  Quantitative analysis 
Cell growth was monitored by measuring the optical density at 600 nm using a UV-
visible spectrophotometer (BioMate 5; Thermo Fisher Scientific). Dry cell weights of engineered 
yeasts on different carbon sources were determined from a plot of optical density and dry cell 
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weight. To calibrate the plot, engineered yeasts were grown in YPD4% and YPX4% 
respectively, harvested by centrifugation at 10,000 rpm, and washed two times with distilled 
water. Washed cell pellets were resuspended in distilled water to various optical densities, and 
filtrated via thoroughly dried cellulose acetate membrane filters. After cell filtration, membrane 
filters were dried to constant weight in an 80°C convection oven and then weighed.  
Concentrations of substrates and extracellular metabolites in culture broth were 
analyzed by Agilent 1200 high performance liquid chromatography (HPLC) system equipped 
with a refractive index detector (Agilent Technologies, Wilmington, DE, United States) and 
Rezex ROA-Organic Acid H+ (8%) column (Phenomenex, Torrance, CA, United States). The 
flow rate of the mobile phase 0.005N H2SO4 was 0.6 ml/min, and the column temperature was 
50˚C. 
To extract and quantify squalene in engineered yeast cells, the previous extraction 
method (Rodriguez et al., 2014) and HPLC determination method (Lu et al., 2004) were 
merged. 1.8 mL of culture media was collected into 2 mL screw-cap tubes by centrifugation at 
13,000 rpm for 5 min, and the cell pellets were washed with distilled water. Washed cell pellets 
were resuspended with 600 L of 20% KOH/50% ethanol (1:1 mixture of 40% KOH and 
absolute ethanol) thoroughly. The tubes were placed in boiled water for 5 minutes and chilled in 
ice. After adding 600 L of hexane and thoroughly vortexing for 5 min, tubes were centrifuged at 
13,000 rpm, 4C for 1 minute. 400 L of hexane (top) layer was moved into a new tube, and the 
volatile hexane was removed by centrifugation with vacuuming in room temperature. Dried 
samples were dissolved in a mixture of 50 L of ethanol and 450 L of acetonitrile, and 
analyzed using Beckman System Gold HPLC system equipped with diode array detector 
(Beckman Coulter, Brea, CA, United States) and Kinetex C18 column (Phenomenex). 100% 
acetonitrile was flowed as a mobile phase at 2 ml/min flow rate. Squalene was detected at 195 
nm, around 15 minute. 
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Amorphadiene trapped in dodecane layer was detected and measured by Gas 
Chromatography-Mass Spectrometry (GC-MS) system of 7890A GC/5975C MSD (Agilent 
Technologies) following the previous protocol (Rodriguez et al., 2014) with small optimizations. 
Since the genuine standard is not commercially available, trans-caryophyllene was used as an 
alternative standard to quantify amorphadiene. To draw a standard curve, caryophyllene 
standards were prepared at 50, 25, 12.5, 6.25, and 3.125 mg/L through serial dilution in ethyl 
acetate. 20 μL of clearly separated dodecane layer was 50 times diluted with 980 μL of trans-
caryophyllene-spiked ethyl acetate (15 mg/L). 1 μL of diluted samples and caryophyllene 
standards were splitlessly injected for the GC-MS analysis using RTX-5Sil MS column (30m x 
0.25mm, 0.25µm; Restek, Bellefonte, PA, United States). The temperature at inlet and MS 
transfer line were held at 250°C. Helium was used as the carrier gas at a constant flow rate of 1 
mL/min, and the oven temperature was held at 100°C for 0.75 min followed by a ramp of 
40°C/min to a final temperature of 250°C for 3 min. The total run time was 7.5 min, and the 
caryophyllene and the amorphadiene peaks appeared at 3.73 and 3.89 min, respectively. The 
peak areas of amorphadiene samples were normalized based on the spiked-internal standard 
caryophyllene and quantified using caryophyllene standard curve. 
 
2.3  Results 
 
2.3.1  Comparison of transcription profiles of engineered yeast cells cultured on 
glucose and xylose 
The global transcriptional profiles of a xylose-fermenting S. cerevisiae strain under 
glucose and xylose conditions (Kim et al., 2015c) demonstrated that the expression levels of 
cytoplasmic alcohol dehydrogenase II (ADH2), aldehyde dehydrogenase (ALD2, ALD3, ALD6), 
and acetyl-CoA synthase (ACS1) were much higher on xylose than glucose conditions (Fig. 
2.2). However, mRNA levels of the genes coding for the enzymes in the MEV pathway enzymes 
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did not change significantly on xylose (Fig. 2.2). As TDH3 and CCW12 have the strongest 
promoters among S. cerevisiae promoters showing similar expression levels on both glucose 
and xylose (Fig. 2.2), PTDH3 and PCCW12 were selected for strong and constitutive expression of 
target genes (TAL1, tHMG1, ERG10, and ADS) in this study.  
 
2.3.2  Construction of a xylose-fermenting strain with enhanced metabolic fluxes in the 
MEV pathway through Cas9-based genome editing 
Cas9-based genome editing was applied for the modification of yeast genome during the 
strain construction process. First, the expression level of TAL1 of the xylose-fermenting strain 
SR7 was increased by substitution of TAL1 promoter with PCCW12 to improve xylose assimilation 
(Xu et al., 2016) and the resulting strain was named HX4. Second, expression cassettes for 
constitutive and strong expression of tHMG1 and ERG10 were integrated into targeted locations 
of the genome of the HX4 strain to increase metabolic fluxes into the MEV pathway. To 
compare the effects of additional expression of tHMG1 and ERG10 on glucose and xylose 
conditions fairly, the TDH3 promoter, showing the same promoter strength on glucose and 
xylose conditions (Fig. 2.2), was used for overexpression of tHMG1 and ERG10. 
An intergenic site in the upstream region of THI72 in chromosome XV was selected for 
integration of the tHMG1 cassette. The tHMG1 overexpressing strain was named HX4H. The 
ERG10 cassette was integrated into a downstream region of YGR190C in chromosome VII of 
the HX4 and HX4H strains to obtain HX4E and HX4HE strains, respectively (Table 2.1). After 
Cas9-based integrations of the tHMG1 and ERG10 cassettes, in vitro enzymatic activities of 
HMG-CoA reductase and acetyl-CoA C-acetyl transferase activities were measured in the four 
engineered strains (HX4, HX4H, HX4E, and HX4HE) grown on glucose and xylose. The 
engineered strains with constitutive tHMG1 expression (HX4H and HX4HE) showed higher 
HMG-CoA reductase activities than all other strains when cultured on either glucose or xylose 
conditions (Fig. 2.3). Interestingly, the endogenous activities of HMG-CoA reductase in the HX4 
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and HX4E strains, which did not harbor the tHMG1 overexpression, were more than 250% 
higher in the cells grown on xylose than glucose (Fig. 2.7a). While additional overexpression of 
tHMG1 reduced the difference of HMG-CoA reductase activities between xylose-grown and 
glucose-grown cells, the xylose-grown cells still showed 60% higher HMG-CoA reductase 
activities (Fig. 2.7b). As expected, the ERG10 overexpressing strains (HX4E and HX4HE) 
showed higher acetyl-CoA C-acetyltransferase activities as compared to other strains (Fig. 2.3). 
 
2.3.3 Comparison of xylose and glucose as carbon sources for accumulation of the 
intracellular squalene 
The engineered xylose-fermenting strains HX4, HX4E, HX4H, and HX4HE were cultured 
on glucose and xylose to observe phenotypic changes with respect to intracellular squalene 
content. Under aerobic culture conditions, three engineered yeasts consumed 43 g/L of glucose 
within 13 hours and 40 g/L of xylose within 34 hours (Fig. 2.4). All strains showed similar 
phenotypes when cultured on glucose conditions regardless of the genetic modifications. When 
cultured aerobically on glucose, the engineered yeast strains quickly fermented glucose 
primarily to ethanol and showed low cell mass titers. Following glucose depletion, ethanol was 
re-utilized as a carbon source (Fig. 2.4a). In contrast, when cultured on xylose, the engineered 
xylose-fermenting yeast strain HX4 consumed xylose slower, showed higher cell mass titers, 
accumulated less ethanol and more acetate as compare to the glucose cultures. Under xylose 
conditions, both the HX4H strain overexpressing tHMG1 and the HX4HE strain co-
overexpressing tHMG1 and ERG10 re-assimilated acetate efficiently (Fig. 2.4b).  
Squalene contents from the harvested cells cultured on glucose and xylose were 
measured after depletion of each carbon source (Fig. 2.5). Single overexpression of tHMwG1 
significantly increased squalene contents regardless of carbon sources. However, single 
overexpression of ERG10 overexpression did not change squalene contents. When ERG10 was 
co-overexpressed with tHMG1, a synergistic effect on squalene content was observed 
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regardless of carbon sources. After depletion of each sugar, co-overexpression of ERG10 with 
tHMG1 increased specific squalene content 44% and 130% on glucose and xylose culture 
conditions, respectively. The ERG10 and tHMG1 co-overexpressing strain (HX4HE) showed 
3.55 and 9.43 mg/g cell of specific squalene content in the cells grown on glucose and xylose. 
The squalene titer of the HX4HE strain on xylose was 8-fold higher than on glucose (18.7 vs. 
150 mg squalene/L) (Fig. 2.5). 
 
2.3.4 Squalene production by the tHMG1 and ERG10 co-overexpressing strain (HX4HE) 
through a xylose fed-batch culture  
As the HX4HE strain co-expressing tHMG1 and ERG10 showed much higher squalene 
contents on xylose than glucose, a fed-batch fermentation based on xylose feeding was 
performed to increase the volumetric productivity of squalene. The HX4HE strain was inoculated 
at an initial cell concentration of 1.2 g cell/L and cultured with 80 g/L of xylose (Fig. 2.6). After 
the initially added xylose was consumed, xylose concentration was maintained in the range of 
15 – 80 g/L through intermittent feedings of xylose. A supplementary fed-batch medium was 
added together with xylose at each feeding point. The HX4HE strain did not accumulate ethanol 
beyond 12 g/L during xylose fed-batch culture despite high concentrations of xylose in the 
medium. As such, cells could grow to high cell densities without growth inhibition from ethanol 
with a specific growth rate of 0.14 h-1. Finally, cell density reached to 83.6 g cell/L and 532 mg/L 
of squalene was produced with a productivity of 11.3 mg/L·h (Fig. 2.6). 
 
2.3.5 Comparison of xylose and glucose as carbon sources for the production of a 
diffusible isoprenoid amorphadinene 
As the tHMG1 and ERG10 co-overexpressing strain (HX4HE) showed enhanced 
production of squalene from xylose, further genetic modifications to produce a diffusible 
isoprenoid, amorphadinene, were introduced into the HX4HE strain. CRISPR-Cas9 based 
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genome editing was used for the additional genetic modifications in the HX4HE strain. 
Specifically, an expression cassette containing A. annua ADS under the control of PCCW12 was 
integrated into the genome of the HX4HE strain, resulting in the construction of the HX4HEA 
strain, to enable the production of amorphadiene from farnesyl pyrophosphate (FPP) (Fig. 2.2). 
To enhance metabolic fluxes from FPP to amorphadiene instead of squalene, the expression of 
ERG9 was down-regulated by substituting the ERG9 promoter with the ERG1 promoter (PERG1) 
and SYH1 promoter (PSYH1), resulting in the construction of the HX4HEA-EE and HX4HEA-ES 
strains, respectively (Table 2.1). Three engineered yeast strains (HX4HEA, HX4HEA-ES, and 
HX4HEA-EE) with different promoters for ERG9 were cultured on glucose and xylose. The 
HX4HEA-ES strain accumulated more glycerol than the parental HX4HEA strain on both 
glucose and xylose conditions, but the HX4HEA-EE strain did not show noticeable phenotype 
changes as compared to the parental strain (HX4HEA) (Fig. 2.10a and 2.10b). Similar to the 
production of squalene, xylose utilization by engineered yeast strains led to higher 
amorphadiene titers and yields than glucose utilization (Fig. 2.10c – 2.10f). The HX4HEA-ES 
strain achieved the highest amorphadiene titer under xylose culture conditions (254 mg/L), while 
the HX4HEA-EE strain produced less amount of amorphadiene than parental strain HX4HEA 
regardless of carbon sources (Fig. 2.10c and 2.10d). 
 
2.4 Discussion 
Since the development of engineered S. cerevisiae capable of utilizing xylose, many 
studies found that xylose utilization leads to dysregulation of glucose-dependent repression, and 
consequently resulted in different transcription patterns of genes involved in glycolysis, redox 
metabolism, mitochondrial metabolism, cytosolic acetyl-CoA synthesis, and so forth, as 
compared to glucose utilization (Jin et al., 2004; Matsushika et al., 2014; Salusjärvi et al., 2008; 
Sonderegger et al., 2004b). Our engineered S. cerevisiae SR7 utilizing both glucose and xylose 
(Kim et al., 2013e) also showed significantly higher expression levels of ADH2, ALD2, ALD3, 
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ALD6, and ACS1, involved in the conversion of ethanol into cytosolic acetyl-CoA, were highly 
expressed when the cells are grown on xylose as compare to glucose (Fig. 2.2). Therefore, we 
hypothesized that the xylose metabolism in the engineered yeast might lead to favorable 
metabolic fluxes to produce cytosolic acetyl-CoA derivatives, such as isoprenoids and fatty 
acids. 
To demonstrate the potential advantages of using xylose over glucose by engineered 
yeast for producing isoprenoids, we chose two isoprenoids: squalene and amorphadiene. 
Squalene is an example of endogenous and intracellular isoprenoids, and amorphadiene is 
heterologous and diffusible isoprenoids. We constructed a platform strain for comparing xylose 
and glucose for the production of two isoprenoids through introducing precise genome 
modifications in a previously engineered xylose-fermenting S. cerevisiae SR7 (Kim et al., 
2013e). The reported genetic perturbations eliciting enhanced xylose fermentation and 
isoprenoid production were introduced using CRISPR-Cas9 based genome editing. Specifically, 
TAL1, ERG10, and tHMG1 were overexpressed for enhancing xylose utilization, increasing 
metabolic fluxes from acetyl-CoA to the MEV pathway, and improving the MEV pathway, 
respectively. The overexpression of the target genes was achieved using the strong and 
constitutive promoters, such as the PCCW12 and the PTDH3 which showed strong and consistent 
expression levels on both glucose and xylose (Fig. 2.2). Functional expressions of tHMG1 and 
ERG10 after furnishing the overexpression cassettes were confirmed through in vitro enzyme 
activity assays using the cells grown on both glucose and xylose conditions (Fig. 2.3).  
When engineered yeast strains used xylose as a carbon source, they showed slower 
sugar consumption, more acetate production, and less ethanol production as compared when 
glucose was used (Fig. 2.4). These phenotype changes are consistently reflecting the RNAseq 
result: higher gene expression levels of ethanol assimilation and acetyl-CoA synthesis pathways 
on xylose condition. Introduction of tHMG1 (the HX4H strain) decreased acetate accumulation 
on xylose, and additional co-expression of ERG10 (the HX4HE strain) resulted in more efficient 
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acetate assimilation than tHMG1 overexpression only (Fig. 2.4b). In addition, we compared 
squalene contents of the engineered yeasts cultured on glucose and xylose (Fig. 2.5). 
Introduction of tHMG1 was critical for squalene synthesis and accumulation in yeast, as 
described in previous reports (Donald et al., 1997; Polakowski et al., 1998). ERG10 co-
expression with tHMG1 increased specific squalene content in yeast cells further, but single 
overexpression of ERG10 had no effect on squalene content. After complete consumption of 
xylose, all engineered yeasts showed higher squalene content and stronger synergistic effect of 
ERG10 co-expression as compared to cultures on glucose. This is indirect evidence that xylose 
metabolism leads to better metabolic flux to acetyl-CoA than glucose metabolism. 
Overexpression of the first step of the MEV pathway, ERG10, increases chance to utilize 
cytosolic acetyl-CoA for the MEV pathway rather than other native competing metabolic 
pathways, such as fatty acid synthesis (Fig. 2.2). The co-overexpression of ERG10 could be 
more effective with xylose utilization because its substrate, cytosolic acetyl-CoA, would be 
accumulated more through xylose utilization than glucose. 
Despite our genetic perturbations to enhance xylose consumption, utilization of glucose 
was still faster than xylose. Therefore, the glucose to squalene culture was extended to the 
ethanol consumption phase beyond glucose depletion (13 hours) to the xylose depletion time 
point (34 hours) for a fair comparison. However, sequential utilization of glucose and ethanol did 
not reach the level of squalene from xylose culture regarding both specific content and 
volumetric titer (Fig. 2.5), although both ethanol and xylose induce higher carbon flux toward 
cytosolic acetyl-CoA (Daran-Lapujade et al., 2004). This could be because of the inhibitory 
effect of ethanol on yeast sterol synthesis. Squalene and total sterol contents of yeast cells can 
be reduced when the cells are grown with excessive amounts of ethanol, and post-
transcriptionally diminished activity of HMG-CoA reductase through exposure to ethanol is one 
of the causes of the reduced levels of squalene and sterols (Walker-Caprioglio et al., 1990). 
Engineered yeast strains in this study accumulated near double amounts of ethanol on glucose 
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(Fig. 2.4), and showed lower activities of HMG-CoA reductase than xylose at the middle of 
exponential phase. This difference between HMG-CoA reductase activities on glucose and 
xylose was consistent regardless of the presence of the tHMG1 overexpression cassette (Fig. 
2.3 and Fig. 2.7).  
Low energy efficiency of yeast glucose metabolism could be another reason behind the 
reduced squalene production from the sequential utilization of glucose and ethanol. Ethanol 
assimilation and isoprenoid biosynthesis require significant amounts of energy. Conversion of 
ethanol to cytosolic acetyl-CoA includes an energetically high-cost reaction of acetyl-CoA 
synthase (2 ATP equivalents), so ethanol utilization of S. cerevisiae restricts maximum yield of 
biomass or products that require ATP (de Kok et al., 2012). The MEV pathway also requires one 
ATP due to the mevalonate kinase (ERG12) reaction. A Crabtree-positive yeast S. cerevisiae 
relies on fermentation during glucose consumption and consequently generates less ATP than 
the amount from respiration (Pfeiffer and Morley, 2014). On the other hand, S. cerevisiae can 
synthesize more ATP under xylose conditions due to dysregulation of glucose-dependent 
repression on components of oxidative phosphorylation, such as cytochrome C oxidase and 
ATP synthase of mitochondria (Alff-Tuomala et al., 2016). The xylose-fermenting SR7 strain 
also showed consistent transcriptional patterns of genes involved in oxidative phosphorylation 
on glucose and xylose cultures (Fig. 2.8). Additionally, due to moderate expression levels of 
ADH2 during xylose utilization (Fig. 2.2), engineered yeasts could simultaneously assimilate 
ethanol. Consequently, engineered yeasts could produce more squalene through simultaneous 
ethanol assimilation and higher ATP supply under xylose conditions as compared to glucose.   
The peculiar physiologic characteristics of engineered yeast during xylose fermentation 
prompted us to investigate the advantages of using xylose as a carbon source for achieving 
high cell density cultures. High cell concentration of microbial cultures is an important factor to 
increase volumetric titers of intracellular proteins and metabolites, such as lipids and squalene. 
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However, S. cerevisiae mainly produces ethanol from fermentable sugars, which is not a 
desirable trait for growth-targeted aerobic cultures due to ethanol-derived damages on growth 
rate and viability of yeast cells (Ingram and Buttke, 1984), and limited energetics and cell growth 
of alcoholic fermentation (Verduyn, 1991). Therefore, several strategies to achieve high density 
cultures on glucose have been developed to circumvent alcoholic fermentation, such as genetic 
modification for eliminating glucose repression or boosting respiratory metabolism (Blom et al., 
2000; Diderich et al., 2001; van Maris et al., 2001; Sasaki and Uemura, 2005), and sugar-limited 
fed-batch cultures (van Hoek et al., 2000; O’Connor et al., 1992; Yamanè and Shimizu, 1984). 
In this study, a high cell density culture of the squalene accumulating engineered yeast was 
demonstrated through xylose feeding instead of further genetic manipulations, or finely tuning 
supply of carbon source. The xylose fed-batch culture maintained high xylose concentrations by 
dumping xylose without using any sophisticated feeding algorithms. Nonetheless, the ethanol 
concentration did not increase over 12 g/L, and cells grew up to 83.6 g/L of cell mass 
concentration with a specific growth rate of 0.14 h-1. As a result, a high squalene titer of 532 
mg/L within 54 h was achieved (Fig. 2.6). However, there was a significant mass balance gap 
between the amount of consumed xylose and the amounts of products including cell mass, 
squalene, ethanol, and other by-products that were detected by HPLC analysis. Ethanol 
vaporization in aerobic yeast culture and insufficient tunings on the MEV pathway could be 
major causes of the low yield of squalene (Drozdíková et al., 2015; Hull et al., 2014). The 
imbalance may also be due to overproduction of undesirable volatile byproducts during xylose 
culture, such as ethyl ester. Activated cytosolic PDH bypass (Fig. 2.2) and higher ATF1 
expression (1.7 times higher on xylose than glucose, P=0.04, data not shown) during xylose 
utilization probably facilitated the esterification of ethanol and acetyl-CoA and the production of 
ethyl ester (Verstrepen et al., 2003; Yoshioka and Hashimoto, 1981).   
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To examine the positive effects of using xylose as a carbon source to produce 
amorphadiene, an ADS expression cassette was additionally introduced into the genome of the 
squalene overproducing strain. To minimize the accumulation of squalene and maximize the 
production of amorphadiene, the promoter of ERG9 (PERG9), coding for squalene synthase, was 
substituted by constitutive and weaker promoters than PERG9. PERG1 was selected as a candidate 
for ERG9 down-regulation according to the previous report (Yuan and Ching, 2015). PSYH1 was 
screened based on our RNA-seq data of the host strain SR7 because of its low and similar 
expression levels on both glucose and xylose (Fig. 2.9). As transcriptional levels of PERG1 and 
PSYH1 on ethanol had not been determined, we calculated amorphadiene yields at the sugar 
depletion point, excluding the periods of ethanol consumption (Fig. 2.10f). Regulation of ERG9 
expression under PSYH1 in the HX4HEA-ES strain led to improved amorphadiene production 
(Fig. 2.10e and 2.10f), while ERG9 expression under PERG1 in the HX4HEA-EE strain did not 
significantly change the phenotype (Fig. 2.10a and 2.10b), and even decreased amorphadiene 
productivity (Fig. 2.10c and 2.10d). As the ergosterol synthetic pathway of S. cerevisiae is 
mostly composed of reduction reactions, higher glycerol accumulation by the HX4HEA-ES strain 
(Fig. 2.10a and 2.10b) is further evidence of successful down-regulation of the ergosterol 
pathway (Su et al., 2015), resulting from promoter substitution of PERG9 to PSYH1. The 
physiological changes after regulation of ERG9 expression under PERG1 were contrary to the 
previous report (Yuan and Ching, 2014), yet still consistent with the RNA-seq data of our host 
strain (Fig. 2.9a). Overall, xylose made a positive effect on the production of amorphadiene as 
well as squalene, regardless of various ERG9 expression levels (Fig. 2.10c, 2.10d, and 2.10e). 
The HX4HEA-ES strain accumulated more glycerol than other engineered strains and showed 
the highest amorphadiene titer and yield on xylose, among all cultures (Fig. 2.10e and 2.10f).  
Our results highlight potential advantages of using xylose as a carbon source for 
biological isoprenoid production, and we envision that the strategies of metabolic engineering 
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coupled with xylose utilization in yeast will actualize economically-feasible bioprocesses for the 
production of isoprenoids and other acetyl-CoA-derived high-value products. 
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2.5  Figures and tables 
 
 
Fig. 2.1 Overview of isoprenoid synthesis in yeast. Glucose and xylose are converted to 
pyruvate through glycolysis, heterologous xylose metabolic pathways (XR, XDH, and XK) and 
pentose phosphate pathway. In the cytosol, pyruvate is converted into cytosolic acetyl-CoA by 
pyruvate decarboxylase (PDC), aldehyde dehydrogenase (ALD), and acetyl-CoA synthase 
(ACS). Yeasts synthesize isoprenoid molecules from cytosolic acetyl-CoA through the 
mevalonate pathway (thick arrows). Squalene is the precursor for the yeast ergosterol 
biosynthesis. IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; GPP, 
geranyl pyrophosphate; FPP, farnesyl pyrophosphate.  
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Fig. 2.2. Transcriptional patterns of the cytosolic PDH bypass and the MEV pathway coding 
genes of the xylose-fermenting SR7 strain on glucose and xylose. Under xylose conditions, it 
showed higher expression levels of cytosolic PDH bypass genes than glucose, but no significant 
changes regarding the MEV pathway. TDH3 and CCW12 of which promoters were used for the 
overexpression in this study, also showed similar expression levels of both glucose and xylose. 
Fold changes were calculated by dividing expression levels of genes on xylose by those on 
glucose. IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; GPP, geranyl 
pyrophosphate; FPP, farnesyl pyrophosphate. *p < 0.05; **p < 0.01; ***p < 0.005. 
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Fig. 2.3 Enzymatic activity assay of HMG-CoA reductase and acetyl-CoA C-acetyltransferase in 
engineered strains. 
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Fig. 2.4 Culture profiles of the engineered yeast strains on glucose (a) and xylose (b) conditions. 
Gray sections of glucose culture graphs indicate the ethanol assimilation phase. DCW, biomass 
concentration based on dry cell weight; circle, HX4; up-triangle, HX4H; down-triangle, HX4E; 
diamond, HX4HE. 
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Fig. 2.5 Squalene production through glucose and xylose utilization of the engineered yeast 
strains. 13 h and 34 h indicate glucose depletion and xylose depletion time point, respectively. 
The gray section indicates the ethanol assimilation phase. 
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Fig. 2.6 Fed-batch culture of the HX4HE strain through dumping xylose. Closed circle, cell 
concentration based on dry cell weight; open circle, squalene; diamond, xylose; up-triangle, 
glycerol; down-triangle, acetate; square, ethanol. 
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Fig 2.7 Specific HMG-CoA reductase activities of engineered S. cerevisiae cultured on glucose 
(gray) and xylose (green) when tHMG1 was not introduced (a) and overexpressed under PTDH3 
(b). Same amount of cells was harvested for activity assays at the middle of exponential phases 
of each strain (Fig. 4, at 12 hour for glucose culture, at 24 hour for xylose culture). The results 
are the means of three independent experiments, and the error bar shows the ±SD. *p < 0.05; 
**p < 0.01; ***p < 0.005.   
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Fig. 2.8 Changes in transcriptional patterns of genes related to oxidative phosphorylation in the 
SR7 strain on xylose as compared to glucose. Complex I, NADH-coenzyme Q oxidoreductase; 
Complex II, succinate:ubiquinone oxidoreductase; Complex III, Q-cytochrome C 
oxidoreductase; Complex IV, ubiquinol cytochrome c oxidase; Complex V, ATP synthase. 
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Fig 2.9 Relative transcriptional levels of squalene synthase (ERG9), squalene epoxidase 
(ERG1), and SYH1 in parental strain SR7 (a) and schematic introduction of promoter 
substitution by CRISPR-Cas9 (b). In (a), grey bars indicate transcriptional levels in the SR7 
strain on glucose, and green bars indicate transcriptional levels in the SR7 strain on xylose 
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Fig. 2.10 Culture profiles of amorphadiene producing yeast strains on glucose (a) and xylose (b). Gray sections of glucose culture 
graphs indicate the ethanol assimilation phase. Amorphadiene concentrations in dodecane layers of glucose culture (light gray) and 
xylose culture (dark gray) were adjusted based on the culture volume (c – e). Amorphadiene yield was calculated at depletion time 
points of each sugar (f). DCW, biomass concentration based on dry cell weight; circle, HX4HEA; square, HX4HEA-EE; up-triangle, 
HX4HEA-ES. 
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Table 2.1 Strains used in this study 
Name Description Reference 
SR7 Xylose-utilizing strain engineered from strain D452-2 (Kim et al., 2013e) 
HX4 SR7 in which PCCW12 has substituted PTAL1 (Xu et al., 2016) 
HX4H HX4 in which the PTDH3-tHMG1-TCYC1 cassette has been integrated on Chr XV This study 
HX4E HX4 in which the PTDH3-ERG10-TCYC1 cassette has been integrated on Chr VII This study 
HX4HE HX4H in which the PTDH3-ERG10-TCYC1 cassette has been integrated on Chr VII This study 
HX4HEA HX4HE in which the PCCW12-ADS-TCYC1 cassette has been integrated on Chr VI This study 
HX4HEA-EE HX4HEA in which PERG1 has substituted PERG9 This study 
HX4HEA-ES HX4HEA in which PSYH1 has substituted PERG9 This study 
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Table 2.2 Plasmids used in this study 
Name Description Reference 
Cas9-NAT Cas9 expression plasmid, NAT1 marker (Zhang et al., 2014) 
pRS425ADS 2µ origin, LEU2, PGAL1-ADS-TCYC1 (Ro et al., 2006) 
pRS42K 2µ origin, KanMX EUROSCARF 
pRS42H 2µ origin, hph EUROSCARF 
pRS42K-CS5 pRS42K, gRNA cassette targeting the intergenic site on Chr XV (Zhang et al., 2016) 
pRS42H-CS6 pRS42H, gRNA cassette targeting the intergenic site on Chr VII This study 
pRS42K-CS8 pRS42K, gRNA cassette targeting the intergenic site on Chr XVI This study 
pRS42H-RC4 pRS42H, gRNA cassette targeting promoter region of ERG9 This study 
pRS425GPD 2µ origin, LEU2, PTDH3, TCYC1  (Mumberg et al., 1995) 
pRS426GPD 2µ origin, URA3, PTDH3, TCYC1  (Mumberg et al., 1995) 
pRS426CCW 2µ origin, URA3, PCCW12, TCYC1  This study 
pRS425GPD-tHMG1 2µ origin, LEU2, PTDH3-tHMG1-TCYC1 This study 
pRS423GPD-ERG10 2µ origin, URA3, PTDH3-ERG10-TCYC1 (Yun et al., 2015) 
pRS426CCW-ADS 2µ origin, URA3, PCCW12-ADS-TCYC1 This study 
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Table 2.3 Primers used in this study 
Name Direction Sequence 
gRNA-U  Sense CCCGAGCTCTCTTTGAAAAGATAATGTATGATTATG 
gRNA-D Antisense AACTGCAGGGATCCAGACATAAAAAACAAAAAAAGCAC 
tHMG1-F Sense GGACTAGTAAAAATGGCTGCAGACCAATTGGTGAAAACT 
tHMG1-R Antisense CCGCTCGAGTTAGGATTTAATGCAGGTGACG 
ADS-F Sense GGACTAGTAAAAATGGCCCTGACCGAAGAG 
ADS-R Antisense CCAAGCTTTCAGATGGACATCGGGTAAAC 
dDNA-CS5-F Sense aaaagagaagaaaaaagagaagaaatgaattctattatgatagcgaatgcAATTAACCCTCACTAAAGGGA 
dDNA-CS5-R Antisense tgctggttgccttattaatttatatggaagacgagataattcattaattaGTAATACGACTCACTATAGGGC 
dDNA-CS6-F Sense aacctcgaggagaagtttttttacccctctccacagatcCAGGAAACAGCTATGACCATG 
dDNA-CS6-R Antisense taattaggtagaccgggtagatttttccgtaaccttggtgtcTGTAAAACGACGGCCAGT 
dDNA-CS8-F Sense caaaattacctacggtaattagtgaaaggccaaaatctaatgttacaataAATTAACCCTCACTAAAGGGA 
dDNA-CS8-R Antisense gaccgttcccttgtgttgtaccagtggtagggttcttctcggtagcttctGTAATACGACTCACTATAGGGC 
dDNA-PERG1-F Sense tataaatggaaagttaggacaggggcaaagaataagagcacagaagaagaGTCGAATACTACTATGACCGC 
dDNA-PERG1-R Antisense gctgccttcatctcgaccggatgcaatgccaattgtaatagctttcccatGACCCTTTTCTCGATATGTTTT 
dDNA-PSYH1-F Sense agttaggacaggggcaaagaataagagcacagaagaagaATTTGCGCTGGTTTTTTAT 
dDNA-PSYH1-R Antisense tcgaccggatgcaatgccaattgtaatagctttcccatCACTTACTGCCACTGCCA 
Conf-CS5-F Sense AATGAATTCTATTATGATAGCGAATGC 
Conf-CS5-R Antisense CACAGGATTTACGAAGACC 
Conf-CS6-F Sense GTCTGCCGAAATTCTGTG 
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Table 2.3 Primers used in this study (cont.) 
Name Direction Sequence 
Conf-CS6-R Antisense CGGTCAGAAAGGGAAATG 
Conf-CS8-F Sense AGTGGAACATAGAAGGGG 
Conf-CS8-R Antisense TAAGCAGCCCAGTGAAC 
Conf-RC4-F Sense CTCCGCAGGAACTACAAA 
Conf-RC4-R Antisense CTCAATTCTGGATGCAGC 
 
Restriction sites are underlined, and homologous regions for dDNA integration are lowercased. Bold characters indicate artificial start 
codon of tHMG1. 
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Table 2.4 Target sequences of gRNA used for CRISPR-Cas9 based genome editing in this 
study 
Name Sequence Description 
CS5 CTGGTAGTTGCACAGAAAGA Upstream of THI72, Chr XV 
CS6 GATACTTATCATTAAGAAAA Downstream of YGR190C, Chr VII 
CS8 TGATTCAATCATTCTTATTG Between YPR015C and YPR014C, Chr XVI 
RC4 GAAAAGACGAAGAGCAGAAG Promoter region of ERG9, Chr VIII 
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CHAPTER III OPTIMIZATION OF GLUCOSE METABOLIC FLUX FOR SESQUITERPENE 
BIOSYNTHESIS IN ENGINEERED YEAST3 
 
3.1 Introduction 
Isoprenoids, a large class of natural compounds formed of isoprene (C5) units into 
various structures, perform as many biological functions as their structural diversity. Isoprenoids 
also have great values in the commercial aspect, as nutraceuticals, antibiotics, and fragrances 
(Chang and Keasling, 2006; Miura et al., 1998; Paradise et al., 2008). Isoprenoids are also 
considered as precursors for next-generation biofuels (Keasling and Chou, 2008). Despite their 
essential roles in living organisms, however, the content of isoprenoids in native organisms is 
too low to achieve commercial level production in general because isoprenoids are the 
secondary metabolites. This low-abundancy of isoprenoids causes expensive and arduous 
extraction process and significant consumption of natural sources (Chang and Keasling, 2006). 
Thus metabolic engineering approaches have been made based on Saccharomyces cerevisiae, 
a genetically amenable workhorse yeast strain of the biotechnology and food industries, to 
overcome the limitation of natural sources by overproducing isoprenoids. All isoprenoids from 
hemiterpenes (C5) to triterpene (C30) can be biosynthesized from two five-carbon precursors, 
isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP) (Ohto et 
al., 2010). S. cerevisiae synthesizes IPP and DMAPP from cytosolic acetyl-Coenzyme A (acetyl-
CoA) through the mevalonate (MEV) pathway (Paltauf et al., 1992). The MEV pathway is linked 
to the ergosterol synthetic pathway in which sterols are compounded from squalene, via geranyl 
pyrophosphate (GPP) and farnesyl pyrophosphate (FPP), C10 and C15 intermediates, 
respectively. Amorphadiene, a potential sesquiterpene (C15) advanced biofuel (Peralta-Yahya 
                                                     
3 The content of this chapter is in preparation for submission. I was the first author of the paper 
and Eun Ju Yun, Eun Joong Oh, Stephan Lane, and Yong-Su Jin were co-authors. Dr. Yong-Su 
Jin was the director of the research. 
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et al., 2012) as well as a valuable precursor for the highly effective antimalarial medicine 
artemisinin, can be synthesized from FPP by a branched heterologous reaction of 
amorphadiene synthase (ADS) (Ro et al., 2006). 
Importantly, both the MEV pathway and the ergosterol synthetic pathway in S. cerevisiae 
require oxidation of plenty of NADPH. The biological redox cofactors NADH/NAD+ and 
NADPH/NADP+ play a key role in numerous enzyme-catalyzed redox reactions. In the case of 
S. cerevisiae, there are more than 200 enzyme reactions, including the MEV pathway and the 
ergosterol synthesis, are involved with redox cofactors. (Chen et al., 2014). The maintenance of 
balance between reduction and oxidation is an indispensable requirement to sustain cellular 
activities of all living organisms. Thus the reduced cofactors, NADH and NADPH, must be re-
oxidized into NAD+ and NADP+ to maintain the redox balance, and vice versa. The native 
balance of cofactor system in living cells can restrict the effect of metabolic engineering 
approaches, such as introduction of heterogeneous pathways or modulation of endogenous, as 
well as be impaired by perturbations on the redox potential (Jain et al., 2012; Scalcinati et al., 
2012; Su et al., 2015; Wang et al., 2013). As examples of sesquiterpene and sterol, α-santalene 
and 7-dehydrocholesterol production in engineered yeasts increased by manipulation of the 
availability of NADPH and NADH, respectively (Scalcinati et al., 2012; Su et al., 2015). 
Previous studies of amorphadiene overproduction in engineered S. cerevisiae have 
mainly focused on the amplification of metabolic fluxes toward IPP and DMAPP by increasing 
expression levels or stabilities of enzymes involved in the MEV pathway and down-regulating 
ERG9 coding for squalene synthase, which consumes FPP to synthesize squalene as a 
precursor for sterol synthesis (Asadollahi et al., 2008, 2010; Baadhe et al., 2013; Paradise et al., 
2008; Ro et al., 2006; Westfall et al., 2012; Yuan and Ching, 2015), but no metabolic 
engineering studies have looked into the correlation between the availability of NADPH and 
amorphadiene production in engineered S. cerevisiae. In this study, I delved into the metabolic 
engineering of redox co-factor NADPH to increase amorphadiene production in engineered S. 
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cerevisiae from glucose. Unlike the previous study about α-santalene production, I focused on 
the effect of slow glycolytic metabolism on metabolic fluxes toward the oxidative pentose 
phosphate pathway (oxPPP), the NADPH availability, and amorphadiene production in 
engineered S. cerevisiae. We discovered that overexpression of oxPPP increase the availability 
of NADPH and amorphadiene titer synergistically when the rate of upper glycolysis was slowed 
down. I concluded that the down-regulation of upper glycolysis is a pre-requisite to increase 
metabolic flux partition toward oxPPP and consequently accrete amorphadiene production, 
especially under glucose culture conditions.  
  
3.2 Materials and methods 
 
3.2.1 Plasmid and donor DNA preparation 
The plasmids, primers, and guide RNA (gRNA) sequences for genome editing used in 
this study are described in Table 3.2, Table 3.3, and Table 3.4, respectively. Polymerase chain 
reaction (PCR) was performed using, unless otherwise stated, Q5® High-Fidelity DNA 
Polymerase (New England Biolab, Ipswich, MA, United States). gRNA expression vectors for 
CRISPR-Cas9 based genome editing were constructed using 2-micron plasmids with antibiotic 
resistance markers, pRS42H and pRS42K (EUROSCARF). Expression cassettes of gRNAs 
guiding Cas9 endonuclease on target nucleotide sequences near the 2172nd base pair of PFK1 
(CS3) and the 2154th base pair of PFK2 (CS4) (Fig 3.2), were synthesized by IDT Inc. 
(Coralville, IA, United States). gRNA cassettes targeting CS3 and CS4 sequences were PCR 
amplified using a gRNA primer set and inserted into pRS42H and pRS42K, respectively. Other 
gRNA plasmids for genetic perturbations on ZWF1 and ERG9 promoter regions, RC1 and RC4, 
respectively, were prepared through ligation-independent FastCloning (Li et al., 2011) based on 
gRNA plasmids pRS42H-CS3 and pRS42K-CS4. Constitutive expression plasmids for ERG10, 
tHMG1, and ADS were constructed based on 2μ multicopy plasmids with auxotrophic markers 
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(Table 2.). Escherichia coli Top10 strain was used for plasmid construction and amplification. E. 
coli strains were aerobically grown in Luria-Bertani medium (5 g/L yeast extract, 10 g/L tryptone, 
and 5 g/L NaCl), at 37˚C, and 100 μg/mL of ampicillin was supplemented if required for the 
selection of transformants. 
Phusion® High-Fidelity PCR Master Mix with HF buffer (New England Biolabs) and 
relevant primer sets were used for PCR amplifications of double-stranded donor DNAs 
(dDNAs). Two dDNAs overlapping point mutation sites of PFK1 and PFK2 were prepared using 
primer sets of dDNA-mPFK1 and dDNA-mPFK2 by overlap extension PCR. dDNAs containing 
promoter sequences of CCW12 (PCCW12) and SYH1 (PSYH1) were PCR amplified from genomic 
DNA of D452-2 strain using primer sets of dDNA-PZC and dDNA-PES, respectively. dDNA PCR 
products were subsequently concentrated and purified through ethanol acetate precipitation. 
 
3.2.2 Strain construction and cultivation 
A description of yeasts used in this study is summarized in Table 1. S. cerevisiae D452-
2 strain (Hosaka et al., 1992) was a starting strain. Yeast Peptone medium (10 g/L yeast 
extract, 20 g/L peptone) containing 20 g/L of glucose (YPD) was prepared for routine yeast 
experiments including CRISPR-Cas9 genome editing. Nourseothricin (100 μg/mL), geneticin 
(300 μg/mL), and hygromycin B (200 μg/mL) were added to YPD medium if required for 
screening. Plasmids and dDNAs were introduced to yeast strains by lithium acetate/single 
strand carrier DNA/polyethylene glycol method (Gietz and Schiestl, 2007). Site-directed 
mutagenesis on PFK1-PFK2 and promoter substitutions for ZWF1 and ERG9 were completed 
by CRISPR-Cas9 based genome editing. The Cas9-NAT plasmid (Zhang et al., 2014) (Addgene 
#64329) was transformed into the D452-2 strain before CRISPR-Cas9 based genetic 
modifications. To construct PFK mutant yeast strains, two gRNA expressing plasmids (pRS42H-
CS3 and pRS42K-CS4) and two dDNAs (dDNA-mPFK1 and dDNA-mPFK2) were 
simultaneously transformed into the D452-2 strain. Correct mutant strains were screened from 
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YPD plates containing Nourseothricin, geneticin, and hygromycin B, then confirmed through 
sequencing of PFK1 and PFK2 mutation regions. To enhance expression levels of ZWF1, 
pRS42K-PZ and dDNA-PZC were transformed into yeast strains. To reduce expression levels of 
ERG9, dDNA-PES was transformed into engineered yeasts together with pRS42H-PE. Correct 
transformants were screened from YPD plates containing proper antibiotics. All and confirmed 
further by colony PCR using confirmation primers (Table 3.3).  
Synthetic complete (SC) medium, which contains yeast nitrogen base and complete 
supplement mixture without histidine, leucine, and uracil (MP Biomedicals, Santa Ana, CA), was 
used to select transformants of auxotrophic marker plasmids and culture the transformants. 20 
g/L of glucose was added to prepare screening plates. Culture experiments under aerobic 
conditions were performed in 50 mL SC medium containing 40 g/L of glucose and 50 mM 
potassium hydrogen phthalate buffer (pH 5.5) in a 250 mL baffled flask. To trap volatile product 
amorphadiene during batch cultures, 5 mL of dodecane was added after filter sterilization using 
Millex®-MP 0.22μm filter unit (EMD Millipore, 255 Billerica, MA, United States). 
 
3.2.3 Glucose 6-phophate dehydrogenase assay 
 To measure glucose 6-phosphate dehydrogenase activities of engineered yeast strains, 
crude cell lysates were extracted as enzyme sources from cells at the mid-exponential growth 
phase by following a previously described procedure (Çağlayan and Wilson, 2014). The enzyme 
reaction was initiated by adding 1 μL of crude cell lysate in a reaction mixture consisting of 171 
μL of 100 mM pH 7.6 triethanolamine buffer, 14 μL of 100 mM MgCl2, 7 μL of 10 g/L glucose-6-
phosphate, and 7 μL of 10 g/L NADP sodium salt hydrate. Assays were conducted by Synergy 2 
microplate reader (Biotek, Winooski, VT, United States) with 96-well plate at 30˚C. The increase 
of NADPH concentration was measured at 340 nm and the NADPH molar extinction coefficient 
6.22 mM-1cm-1 was used for calculation. One glucose 6-phosphate dehydrogenase activity unit 
was defined as the amount of enzyme catalyzing the reduction of 1 µmol of NADP per minute. 
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Activities were normalized by protein concentration of reaction mixtures. Protein concentrations 
were measured using PierceTM BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, 
United States). 
 
3.2.4 Analyses of intracellular metabolites and redox cofactors 
To analyze intracellular metabolites, extracts were prepared by the fast filtration method 
(Kim et al., 2013a) with small modifications. Cells were vacuum-filtered through nylon 
membrane filters (0.45 μm pore size, 13 mm diameter; Whatman, Piscataway, NJ, United 
States) at the mid-exponential phase, and washed by filtrating 2 mL of distilled water at room 
temperature. Filters and washed cells were quickly mixed with 1 mL of acetonitrile/water mixture 
(1:1, v/v) and 0.1 g of glass beads (0.5 mm diameter) in 1.5 mL tubes by vigorous vortexing for 
5 min. The extraction mixtures were then centrifuged at maximum rpm and 4˚C for 10 min. 500 
μL of supernatants were collected and then vacuum-dried. 5 μL of 40 g/L methoxyamine 
hydrochloride in pyridine was added to dried samples and mixtures were incubated at 30˚C for 
90 min. 45 μL of N-methyl-N-trimethylsilyltrifluoroacetamide were then added to the mixtures 
and incubated at 37˚C. Derivatized samples were analyzed by gas chromatography-mass 
spectrometry (GC-MS) 7890A GC/5075C MSD system (Agilent Technology, Wilmington, DE, 
United States) and RTX-5Sil MS column (30 m × 0.25 mm, 0.25 μm; Restek, Bellefonte, PA, 
United States). Helium constantly flowed at 1 mL/min as a carrier gas. Glucose 6-phosphate 
and fructose 6-phosphate were identified by comparing retention time values and mass 
spectrums of standard chemicals. 
107 cells of engineered yeasts were harvested at both middle of exponential phase and 
ethanol consuming phase. To measure levels of redox cofactor NADPH and NADP+, cells were 
harvested by centrifugation at 13,000 rpm and 4˚C for 10 min. Cell pellets were washed by 
using ice cold distilled water. NADPH and NADP+ were extracted from yeast cells and 
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colorimetrically determined by EnzyChromTM NADP+/NADPH Assay Kit (BioAssay Systems, 
Hayward, CA, United States) and Synergy 2 microplate reader with 96-well plate.  
 
3.2.5 Quantitative analyses 
Cell growth was monitored by absorbance at 600 nm (A600) using BioMate 5 UV-visible 
spectrophotometer (Thermo Fisher Scientific). Glucose, glycerol, acetate, and ethanol 
concentrations were determined by Agilent 1200 high performance liquid chromatography 
(HPLC) system equipped with a refractive-index detector (Agilent Technologies). The mobile 
phase 0.005 N H2SO4 was eluted through Rezex ROA-Organic Acid H+ (8%) column 
(Phenomenex, Torrance, CA, United States) at a flow rate of 0.6 mL/min and 50˚C.  
Amorphadiene in dodecane layer was quantified by gas chromatography-mass 
spectrometry (GC-MS) 7890A GC/5075C MSD system (Agilent Technology) and RTX-5Sil MS 
column (30 m × 0.25 mm, 0.25 μm; Restek) with helium as a carrier gas. The temperature of 
inlet and MS transfer line were 250C. The initial oven temperature was 150C for 0.75 min 
followed by a ramp of 40°C/min to a final temperature of 250°C for 3 min. 20 μL of dodecane 
layer was clearly separated from cultures and mixed with 980 μL of ethyl acetate which was 
spiked by 15 mg/L of trans-caryophyllene. 1 L of samples and trans-caryophyllene standards 
were injected without a split. The caryophyllene and the amorphadiene peaks appeared at 3.73 
and 3.89 min, respectively. Amorphadiene concentration was calculated using the trans-
caryophyllene standard curve (Rodriguez et al., 2014). 
 
3.3 Results 
 
3.3.1 Construction and phenotypic characterization of PFK, ZWF1, and ERG9 mutant S. 
cerevisiae strains 
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 Site-directed mutagenesis on PFK1 (Ser724Asp) and PFK2 (Ser718Asp) were 
completed through CRISPR-Cas9 based genome editing without additional alterations in terms 
of amino acid sequence (Fig 3.2a–c). The resulting strain was named SK1. A strong constitutive 
promoter PCCW12 was introduced in front of ZWF1 coding sequences to enhance expression 
levels of ZWF1 in D452-2 and SK1 (Fig. 3.3a), and the resulting strains were named DZ and 
SZ, respectively. Through similar strategy, PSYH1, a weaker promoter as compared to PERG9, was 
integrated on upstream region of ERG9 in engineered yeasts D452-2, DZ, SK1, and SZ, to 
regulate metabolic fluxes of FPP toward squalene and ergosterol biosynthesis. The resulting 
strains were named De, DZe, Se, and SZe, respectively. Empty plasmids, pRS423, pRS425, 
and pRS426 were introduced into the engineered yeasts to compare phenotypes of parental 
and engineered strains without genetic perturbations on the MEV pathway. Substitution of PZWF1 
with PCCW12 caused the increase of glucose-6-phosphate dehydrogenase (G6PD) activities of 
engineered DZ and SZ strains (Fig. 3.3b). PFK mutant strains harboring empty plasmids 
showed a noteworthy decrease in glycerol yield as compared to parental D452-2 based strains, 
while they did not exhibit noticeable changes in ethanol yields (Fig 3.4a and b). 
 
3.3.2 Changes in the availability of NADPH in engineered yeasts  
 Before the introduction of genetic perturbations on the MEV pathway, cellular levels of 
NADPH and NADP+ in engineered yeasts were measured plasmids at both mid-exponential 
phase (glucose consumption phase) and following ethanol consumption phase. During glucose 
utilization, overexpression of ZWF1 in Se (SZe) exhibited noticeable increase of 
[NADPH]/[NADP+] ratio, while ZWF1 overexpressing alone in the parental strain (DZe) 
marginally increased [NADPH]/[NADP+] ratio as compared to the parental strain (De). Se strain 
showed similar [NADPH]/[NADP+] ratio with DZe strain (Fig. 3.5a). On ethanol, all engineered 
strains exhibited higher [NADPH]/[NADP+] ratios as compared to on glucose. Strains did not 
show a significant difference among them under ethanol conditions. 
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3.3.3 Changes in glycolysis intermediate patterns in engineered yeasts 
 SK1 based yeast strains, whose positive regulation machinery was disturbed, exhibited 
significantly higher levels of glucose 6-phopshate and fructose 6-phosphate as compared to 
wild-type-based yeast strains during glucose utilization. Interestingly, ZWF1 overexpression 
increased intracellular levels of glucose 6-phosphate and fructose 6-phosphate in both PFK 
mutant and wild-type yeast strains, although G6PD catalyzes glucose 6-phosphate utilizing 
metabolism, oxPPP. During ethanol utilization, all engineered yeast strains exhibited similar 
levels of glucose 6-phosphate and fructose 6-phoshate (Fig. 3.6). 
 
3.3.4 Production of amorphadiene by engineered yeasts shunting glycolysis into oxPPP 
After confirming that the combination of ZWF1 overexpression and mutant PFK1-PFK2 
synergistically increased NADPH availabilities, episomal expression plasmids for tHMG1, 
ERG10, and ADS substituted empty plasmids to demonstrate enhanced production of 
amorphadiene in the engineered yeast strains. After 40 g/L of initial glucose was depleted, 
cultures were continued by depletion point of ethanol produced during glucose fermentation to 
allow yeast strains to synthesize amorphadiene from ethanol (gray sections). As hypothesized, 
SZe with episomal tHMG, ERG10, ADS overexpression (SZe-EHA) achieved the highest 
amorphadiene titer (497 mg/L), which was 395% higher than negative control strain De-EHA 
(126 mg/L). Yeast strains of ZWF1 overexpression alone (DZe-EHA) and PFK1-PFK2 mutation 
alone (Se-EHA) showed 295 mg/L and 266 mg/L of amorphadiene titer, respectively (Fig 3.7). 
Amorphadiene yields of engineered strains were compartmentalized by glucose 
consumption phase (0–39 h) and ethanol consumption phase (88–234 h) and calculated. On 
glucose consumption phase, mutant PFK1-PFK2 (Se-EHA) and ZWF1 overexpression (DZe-
EHA) increased the amorphadiene yield of engineered yeasts, and the combination of the two 
genetic perturbations (SZe-EHA) achieved the highest amorphadiene yield (6.73 mg/L) (Fig. 
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3.8a). During ethanol utilization, mutant PFK1-PFK2 did not affect amorphadiene production, 
while ZWF1 overexpression effectively increased the yield of amorphadiene.  
 
3.4 Discussion 
S. cerevisiae synthesizes precursors of isoprenoids and sterols from cytosolic acetyl-
CoA through the MEV pathway which requires a significant amount of NADPH as a redox 
cofactor. Cellular NADPH and its oxidized form NADP+ have tightly regulated in yeast cells. 
Consequently, overproduction of isoprenoids in S. cerevisiae may be restricted by native redox 
homeostasis. Therefore, the native balance between NADPH and NADP+ was perturbed in this 
study. During utilization of fermentable sugars including glucose, generation of NADPH in S. 
cerevisiae highly depends on oxPPP and NADP+-dependent aldehyde dehydrogenase (Ald6p), 
despite another enzymatic NADPH source, cytosolic NADP+-specific isocitrate dehydrogenase 
(IDP2) (Minard and McAlister-Henn, 2005). As Ald6p is involved in the native synthetic pathway 
for cytosolic acetyl-CoA, oxPPP was targeted to modulate its metabolic flux and increase 
NADPH regeneration capability in engineered yeasts. 
Fructose 2,6-bisphosphate is a strong allosteric up-regulator of PFK in the eukaryotic 
system (Van Schaftingen et al., 1980). In the case of S. cerevisiae, fructose 2,6-bisphosphate is 
synthesized from fructose 6-phosphate by two 6-phosphofructo-2-kinase isozymes, which are 
encoded by PFK26 and PFK27, respectively (Boles et al., 1996). Two S. cerevisiae PFK 
isozymes Pfk1p and Pfk2p have a fructose 2,6-bisphosphate-binding serine site. Point 
mutations in the binding site of both PFK isozymes delayed growth, glucose consumption, and 
ethanol production of mutant yeast strains (Heinisch et al., 1996). The absence of the 
interaction between the allosteric up-regulator and PFK isozymes also caused accumulation of 
intermediates of upper glycolysis, such as glucose 6-phosphate and fructose 6-phosphate 
(Boles et al., 1996).  
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To increase metabolic fluxes of glucose 6-phosphate into oxPPP, ZWF1 encoding the 
initiating enzyme G6PD was overexpressed under strong constitutive promoter PCCW12 in 
parental strain D452-2 (DZ). Despite high in vitro G6PD activities of engineered yeast DZ (Fig. 
3.3b), ZWF1 overexpression did not result in an impressive increase of cellular 
[NADPH]/[NADP+] ratios as compared to changes in G6PD activities (Fig 3.4a). This could be 
because of not only the native regulation of G6PD by NADPH (Llobell et al., 1988), but also 
rapid upper glycolysis fluxes of S. cerevisiae under glucose culture conditions (Beullens et al., 
1988). When S. cerevisiae confronts high concentration of glucose, it exhibits high catalytic 
activities of phosphorylation in upper glycolysis, especially the phosphofructokinase (PFK) 
reaction (Zampar et al., 2013). As upper glycolysis and oxPPP share glucose 6-phosphate as 
an intermediate, I hypothesized that increase of the “pull” on glucose 6-phosphate by down-
regulating glycolytic activities of upper glycolysis is necessary to maximize the “push” to oxPPP 
through ZWF1 overexpression. SK1 strain whose PFK isozymes have a point mutation in 
allosteric regulator binding site was constructed by CRISPR-Cas9 genome editing without 
additional alterations of amino acid sequences in order to increase availabilities of glucose 6-
phosphate in engineered yeast strains. Expression of ERG9 was subsequently down-regulated 
by substituting PERG9 with PSYH1, a weaker constitutive promoter than PERG9, to decrease 
metabolic flux partition toward sterol synthesis. D452-2 and SK1 based strains harboring 
swapped promoters in front of ZWF1 and/or ERG9 were cultured under aerobic and glucose 
culture conditions without genetic perturbations on the target sesquiterpene production pathway 
to see the effect of glycolytic flux modifications on phenotypes and NADPH availabilities of 
engineered yeasts.  
SK1 based engineered S. cerevisiae showed lower glycerol regardless of additional 
genetic perturbations (Fig. 3.4a and b). Glycerol biosynthesis in yeast is known to be necessary 
to re-oxidize surplus NADH formed in the biosynthesis (Bakker et al., 2001) and protect cells 
from low extracellular water activity (André et al., 1991; Nevoigt and Stahl, 1997). Recent 
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studies revealed another homeostatic role of yeast glycerol biosynthesis to balance between 
demand and supply of cytosolic inorganic phosphate (Pi) (van Heerden et al., 2014). Pi is a 
biological form of phosphorus which is involved in the biosynthesis of various cellular 
constituents and metabolisms including glycolysis (Dick et al., 2011). Glycolysis can be divided 
into two stages: upper-part of glycolysis consists of two phosphorylation and a cleavage which 
consequently produce two 3-carbon sugar phosphates from glucose, and lower-part of 
glycolysis converts the two 3-carbon sugar phosphates into pyruvate. When the Crabtree 
positive yeast S. cerevisiae confronts high concentration of glucose, it rapidly phosphorylates 
glucose via upper glycolysis, and consumes ATP and decreases cellular inorganic phosphate 
levels before lower glycolysis compensates (van Heerden et al., 2014). To buffer decrease in Pi, 
yeast has two native Pi generating metabolic pathways, the trehalose pathway, which also can 
inhibit hexokinases, and the glycerol pathway (Fig 3.4c). Thus knockout mutant of trehalose 
pathway induces glycerol overproduction in yeast to compensate the lack of Pi (van Heerden et 
al., 2014; Luyten et al., 1995). Considering that there was no significant change in the ethanol 
yield of each strain, glycerol yields of mutant yeast strains decreased not because of redox 
balance of NADH and NAD+, but point mutations of PFK1 and PFK2 successfully down-
regulated the phosphorylation of fructose 6-phosphate. 
Since ethanol also can be assimilated for biosynthesis of cytosolic acetyl-CoA and 
isoprenoid (Daran-Lapujade et al., 2007; Westfall et al., 2012), the NADPH availability was 
determined during both glucose consumption and ethanol consumption by measuring 
intracellular levels of NADPH and NADP+. During glucose consumption, ZWF1 overexpression 
in Se strain (SZe) more effectively increased [NADPH]/[NADP+] ratios as compared to ZWF1 
overexpression in the parental strain (DZe). Interestingly, Se strain also exhibited a similar level 
of the [NADPH]/[NADP+] ratio with DZe strain during glucose consumption (Fig 3.5a). It implies 
that, under glucose conditions, the weak catalytic activity of upper glycolysis itself also could 
increase as much metabolic flux from glucose 6-phosphate toward oxPPP as ZWF1 
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overexpression did. A similar mechanism, which increases the flux partition toward oxPPP and 
the NADPH availability by diminishing the allosteric interaction between PFK and fructose 2,6-
bisphosphatre, was recently discovered in cancer cells (Yamamoto et al., 2014). During ethanol 
consumption, although engineered yeast strains showed overall higher levels of the 
[NADPH]/[NADP+] ratio as compared to the ratios under glucose conditions, there were no 
significant differences among the strains (Fig. 3.5b). I measured actual glucose 6-phosphate 
and fructose 6-phosphate levels in engineered yeast strains during both glucose utilization and 
ethanol utilization, and found that mutations on PFK efficiently triggered the accumulation of 
glucose 6-phosphate only during glucose utilization (Fig. 3.6). Interestingly, ZWF1 
overexpression led to higher glucose 6-phosphate and fructose 6-phosphate levels in both wild-
type and PFK mutant strains. This might be due to the enhanced circulation of glucose 6-
phosphate through oxPPP, non-oxPPP, and phosphoglucoisomerase. 
Since the native homeostasis mechanism for NADPH could hinder reading actual 
NADPH availabilities from [NADPH]/[NADP+] ratio values, I introduced episomal expression 
vectors for ERG10, tHMG1, and ADS to see differences in the NADPH availability of each strain 
via amorphadiene. Overexpression of ERG10, tHMG1, and ADS allowed engineered yeast 
strains to produce amorphadiene from glucose. Patterns of amorphadiene production and 
[NADPH]/[NADP+] ratios of each engineered yeast strain were coherent during glucose 
consumption (0 h – 38 h), and indicated that ZWF1 overexpression effectively increased the 
NADPH availability when PFK isozymes could not interact with allosteric up-regulator so that 
SZe-EHA strain could produce more amorphadiene from glucose (Fig. 3.5a, Fig. 3.7, and Fig. 
3.8a). On the other hand, during ethanol consumption (88 h – 234 h), amorphadiene production 
in engineered strains showed strong positive correlation with ZWF1 expression levels, but point 
mutations on PFK1 and PFK2 did not affect amorphadiene production (Fig. 3.8b). Patterns of 
amorphadiene production on glucose and ethanol clearly reflected native changes in S. 
cerevisiae glycolytic flux by glucose-dependent stimulation (Beullens et al., 1988; Zampar et al., 
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2013). Consequently, the highest amorphadiene titer 497 mg/L was achieved from 45 g/L of 
glucose by SZe-EHA strain, which showed high amophadiene yield on both glucose and ethanol 
consumption phases. 
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3.5 Figures and tables 
 
  
Fig. 3.1 Experimental concept of NADPH regeneration through oxidative pentose phosphate 
pathway. Half red box of PDH bypass indicates that the metabolism generates both NADH and 
NADPH through its reactions. 
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Fig. 3.2 Graphical introduction of mutagenesis on PFK1 and PFK2 by CRISPR-Cas9 (a) and 
detailed information for dDNA and actual changes in DNA and amino acid sequences of PFK1 
(b) and PFK2 (c). 
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Fig. 3.3 Schematic introduction of promoter substitutions for ZWF1 and EFG9 by CRISPR-Cas9 
(a) and in vitro activities of G6PD of engineered yeasts (b). 
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Fig. 3.4 Biomass yield, glycerol yield, and ethanol yield of engineered yeasts before ERG9 
down-regulation (a) and after ERG9 down-regulation (b) under PSYH1. Anticipated steady-states 
of sugar phosphate intermediates in upper glycolysis and the balance of inorganic phosphate 
(Pi) in glycolysis, trehalose pathway, and glycerol pathway (c). mt, point mutations on PFK1 and 
PFK2; O, overexpression; D, down-regulation; T6-P, trehalose 6-phosphate; G6-P, glucose 6-
phosphate; F6-P, fructose 6-phosphate; F2,6-bP, fructose 2,6-bisphosphate; F1,6-bP, fructose 
1,6-bisphosphatre, DHA-P, dihydroxyacetone phosphate; GA3-P, glyceraldehyde 3-phosphate; 
Gly3-P, glycerol 3-phosphate; G1,3-bP, glycerate 1,3-bisphosphate (1,3-bisphosphoglycerate); 
oxPPP, oxidative pentose phosphate; non-oxPPP, non-oxidative pentose phosphate pathway. 
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Fig. 3.5 [NADPH]/[NADP+] ratio during glucose consumption phase (middle of exponential 
phase) (a) and following ethanol consumption phase (b). 
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Fig. 3.6 Patterns of availabilities of upper glycolysis intermediates glucose 6-phosphate and 
fructose 6-phosphate in engineered yeast strains during glucose utilization and ethanol 
utilization. G6-P, glucose 6-phosphate; F6-P, fructose 6-phosphate. 
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Fig 3.7 Culture profiles of engineered yeast strains harboring the MEV pathway (ERG10 and tHMG1) and amorphadiene synthase 
(ADS) expressing plasmids. Gray boxes indicate ethanol consuming phase.
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Fig 3.8 Amorphadiene yield of engineered yeasts during glucose consumption (a) and ethanol 
consumption (b). mt, point mutations on PFK1 and PFK2; O, overexpression. ERG9 of all 
strains were down-regulated under PSYH1.
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Table 3.1 Strains used in this study 
Name Description Reference 
D452-2 (D) S. cerevisiae, MATα, leu2, his3, ura3, and can1 (Hosaka et al., 1992) 
DZ D452-2, ZWF1 overexpression under PTDH3 This study 
SK1 (S) D452-2, mutant PFK1 (Ser724Asp), mutant PFK2 (Ser718Asp) This study 
SZ SK1, ZWF1 overexpression under PTDH3 This study 
De D452-2, ERG9 underexpression under PSYH1  This study 
DZe DZ, ERG9 underexpression under PSYH1  This study 
Se SK1, ERG9 underexpression under PSYH1 This study 
SZe SZ, ERG9 underexpression under PSYH1 This study 
De-EHA De expressing ERG10, tHMG1, and ADS in multicopy plasmids This study 
DZe-EHA DZe expressing ERG10, tHMG1, and ADS in multicopy plasmids This study 
Se-EHA Se expressing ERG10, tHMG1, and ADS in multicopy plasmids This study 
SZe-EHA SZe expressing ERG10, tHMG1, and ADS in multicopy plasmids This study 
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Table 3.2 Plasmids used in this study 
Name Description Reference 
Cas9-NAT Cas9 expression plasmid, NAT1 marker (Zhang et al., 2014) 
pRS42K 2µ origin, KanMX EUROSCARF 
pRS42H 2µ origin, hph EUROSCARF 
pRS42K-CS3 pRS42K, gRNA cassette targeting the point mutation site of PFK1 This study 
pRS42H-CS4 pRS42H, gRNA cassette targeting the point mutation site of PFK2 This study 
pRS42K-RC1 pRS42H, gRNA cassette targeting promoter region of ZWF1 This study 
pRS42H-RC4 pRS42H, gRNA cassette targeting promoter region of ERG9 This study 
pRS423TDH 2µ origin, HIS3, PTDH3, TCYC1  (Mumberg et al., 1995) 
pRS425TDH 2µ origin, LEU2, PTDH3, TCYC1  (Mumberg et al., 1995) 
pRS426CCW 2µ origin, URA3, PCCW12, TCYC1  This study 
pRS423TDH-ERG10 2µ origin, HIS3, PTDH3-ERG10-TCYC1 (Yun et al., 2015) 
pRS425TDH-tHMG1 2µ origin, LEU2, PTDH3-tHMG1-TCYC1 This study 
pRS426CCW-ADS 2µ origin, URA3, PCCW12-ADS-TCYC1 This study 
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Table 3.3 Primer sets used in this study 
Name Direction Sequence 
gRNA Sense CCCGAGCTCTCTTTGAAAAGATAATGTATGATTATG 
 Antisense AACTGCAGGGATCCAGACATAAAAAACAAAAAAAGCAC 
tHMG1 Sense GGACTAGTAAAAATGGCTGCAGACCAATTGGTGAAAACT 
 Antisense CCGCTCGAGTTAGGATTTAATGCAGGTGACG 
ADS Sense GGACTAGTAAAAATGGCCCTGACCGAAGAG 
 Antisense CCAAGCTTTCAGATGGACATCGGGTAAAC 
FC-PZ Sense [ATAGAATAGAAAACCACATA]GTTTTAGAGCTAGAAATAGCAAG 
 Antisense [TATGTGGTTTTCTATTCTAT]CGATCATTTATCTTTCACTGCGGA 
FC-PE Sense [GAAAAGACGAAGAGCAGAAG]GTTTTAGAGCTAGAAATAGCAAG 
 Antisense [CTTCTGCTCTTCGTCTTTTC]CGATCATTTATCTTTCACTGCGGA 
dDNA-mPFK1 Sense gaacccaacacccaatctttaacattccaatgtgtttgattccagcaactgttgataaca 
 Antisense caggtatcaacaccaagtgagtattcagtacctggaacgttgttatcaacagttgctgga 
dDNA-mPFK2 Sense agctttcagaatcccaatggtcttgataccagctactttggataacaatgttccaggtactgaatactct 
 Antisense acaacatcacagtattccattagagcattcaaagcggtatcagaacctaaagagtattcagtacctggaa 
dDNA-PZC Sense tcccccttccccctctccaattggctgtatagacagaaagagtaaatcca CCACCCATGAACCACAC 
 Antisense aagacagatatgacggtatttttttcgaatttgacggggccttcactcat TATTGATATAGTGTTTAAGCGAATG 
dDNA-PES Sense agttaggacaggggcaaagaataagagcacagaagaaga ATTTGCGCTGGTTTTTTAT 
 Antisense tcgaccggatgcaatgccaattgtaatagctttcccat CACTTACTGCCACTGCCA 
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Table 3.3 Primer sets used in this study (cont.) 
Restriction sites are underlined. Bold characters indicate artificial start codon of tHMG1. New target sequence regions in fast cloning 
primers (FC) were bracketed. Homologous regions for dDNA integration are lowercased. Point mutation sites were Italicized and 
underlined.  
Name Direction Sequence 
Conf-PFK1 Sense GCCAGTATCTGACAGACTAAACAT 
 Antisense GCTCATTGTTATGTGTATCATATCG 
Conf-PFK2 Sense CCATTGTTAATGTCGGTGCT 
 Antisense GATAATATTGGTTTCATGGGGTAG 
Conf-PZ Sense TTTGGCTCAAGGTGTGG 
 Antisense CCATCTTGAAGAACTGTTCG 
Conf-PE Sense TCTGTTCTTTCGTCCCG 
 Antisense CCGATGATAGATTTGCCC 
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Table 3.4 Target sequences of gRNA used for CRISPR-Cas9 based genome editing in this 
study 
Name Sequence Description  
CS3 TGGAACGTTGTTAGAAACAG Middle of PFK1, Chr VII 
CS4 TCCAGGTACTGAATACTCTT Middle of PFK2, Chr XIII 
RC1 ATAGAATAGAAAACCACATA Promoter region of ZWF1, Chr XIV 
RC4 GAAAAGACGAAGAGCAGAAG Promoter region of ERG9, Chr VIII 
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CHAPTER IV METABOLIC ENGINEERING APPROACHES TO MANIPULATE PROBIOTIC 
ACTIVITIES OF YEAST 
 
4.1 Introduction 
Saccharomyces boulardii is acknowledged as generally regarded as safe (GRAS) by the 
Food and Drug Administration (FDA) and has been commercially utilized as a probiotic yeast 
strain in food and nutraceutical industries for GI disorders, such as diarrhea (Liu et al., 2016). S. 
boulardii has high genetic similarity to the brewer’s yeast S. cerevisiae, and both yeast strains 
are accordingly sorted as a member of the same species (Edwards-Ingram et al., 2007). 
However, S. boulardii is more thermotolerant and acidoteolerant than S. cerevisiae. Therefore 
S. boulardii shows better viability when exposed to the gastric environment as compared to S. 
cerevisiae (Fietto et al., 2004). Additionally, S. boulardii shows higher mannoprotein portion and 
lower glucan portion of cell wall carbohydrates than S. cerevisiae (Bzducha-Wróbel et al., 2013). 
Yeast cell wall contributes 10-25% of dry yeast cell mass, and consists of mannoproteins 
(~48%), -glucans (1,6--glucan and 1,3--glucan, ~50%), and chitin (~2%) (Orlean, 2012). 
Carbohydrate moieties of mannoproteins determine characteristics and functions of individual 
proteins and regulate cell wall permeability (De Groot et al., 2005). Yeast machinery of 
oligosaccharidic modifications of cell wall mannoproteins start initial attachment of sugar units in 
the endoplasmic reticulum (ER) lumen, and the glycans are further modified in the Golgi before 
the glycoproteins are deposited in the plasma membrane (Lesage and Bussey, 2006). Around 
1200 genes in budding yeast are involved in cell wall biosynthesis and maintenance (de Groot 
et al., 2001), and the synthetic process of the cell wall is tightly controlled according to cell cycle 
or environmental conditions (Aguilar-Uscanga and François, 2003). 
Although S. boulardii does not have capabilities to colonize on host gut epithelial cells 
(Edwards-Ingram et al., 2007), the yeast actively interacts with mammalian host and 
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microorganisms at the gastrointestinal track via mannan molecules on its cell wall 
mannoproteins when administrated. First, administration of S. boulardii or its mannan activates 
the gut mucosal immune system by stimulating the secretion of immunoglobulin A (IgA), 
(Gómez-Verduzco et al., 2009; Kudoh et al., 1999; Swanson et al., 2002). Secretory IgA serves 
as a defense mechanism protecting intestinal epithelium from pathogenic bacteria and toxins 
including Clostridium difficile toxins (Castagliuolo et al., 1999; Qamar et al., 2001). Second, S. 
boulardii exhibits an adhesive interaction against pathogenic bacteria such as Salmonella 
enterica Typhimurium and Escherichia coli causing acute infectious diarrhea (Gedek, 1999; 
Tiago et al., 2012). The adhesion activity is originated in the interaction between yeast cell wall 
mannan and mannose-sensitive bactereial lectins (Gedek, 1999). Thus dead S. boulardii cells 
show same adhesion activity to S. enterica and E. coli as compared to live cells (Tiago et al., 
2012). As S. boulardii does not colonize in the host gastrointestinal track, the pathogenic 
bacteria bound to the surface of S. boulardii are eliminated by the flow of secretion or fluids 
lining the epithelial surfaces (Krogfelt, 1991).  
Administration of S. boulardii mannan also maintains the natural or beneficial 
composition of the host gut microbiota as a selective nutrition. The microbial communities in the 
colon or rumen of mammalian host efficiently degrade intractable substrates which host 
digestive system cannot degrade. However, only particular organisms “keystone species” have 
the capability to initiate degradation of such substrates. The rest of the microbial communities 
that can utilize only degraded smaller oligosaccharides depends on the initiation of degrading 
the original resistant substrates (Ze et al., 2013). In the case of yeast cell wall mannan, a part of 
Bacteroidetes including Bacteroides thetaiotaomicron, a dominant and commensal member of 
human gut microbiota, act as the keystone species (Cuskin et al., 2015; Hemarajata and 
Versalovic, 2013). However, the keystone Bacteroidetets species utilize yeast mannan through 
a selfish machinery of Sus (starch utilization system)-like system (Cuskin et al., 2015; Martens 
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et al., 2009) so that most gram-positive bacteria including Clostridia cannot easily access to 
mannan of digestible sizes (Abbott et al., 2015). This mechanism might allow administration of 
S. boulardii to change the ratio between Bacteroidetes and Fermicutes in mammalian host gut 
microbiota (Everard et al., 2014).  
The aim of the present study was to investigate a correlation between yeast probiotic 
activities and cell wall mannan contents, and consequently control yeast probiotic activities by 
modulating its cell wall mannan. To demonstrate positive correlations between probiotic 
activities and cell wall mannan content, I first improved metabolic flux toward biosynthesis of 
GDP-mannose, the only substrate of the mannosylation of yeast cell wall proteins. To increase 
further or decrease cell wall mannan content in engineered yeasts, expression levels of genes 
encoding cell wall mannoprotein and enzymes involved in mannosylation process of 
endoplasmic reticulum and Golgi were manipulated. Consequently, engineered S. bouardii and 
S. cerevisiae strains showing various levels of cell wall mannan were constructed, and their 
adhesion activities toward pathogenic bacteria were measured. 
 
4.2 Materials and methods 
 
4.2.1 DNA preparation 
 The Cas9-NAT plasmid (Addgene #64329) was previously constructed for the 
introduction of Cas9 RNA-guided endonuclease in yeast cells (Zhang et al., 2014). Guide RNA 
(gRNA) expression cassettes consisting of the gRNA sequence (Table 4.4), SNR52 promoter, 
and SUP4 flanking region were synthesized from IDT Inc. (Coralville, IA, United States). gRNA 
cassettes were amplified by polymerase chain reaction (PCR) using gRNA-U and gRNA-D 
primers, digested with SacI and KpnI, and introduced into 2-micron plasmids pRS42H and 
pRS42K (EUROSCARF). Double-stranded donor DNAs (dDNAs) for deletions of PFK26 and 
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PFK27 were prepared by overlap extension PCR using primer sets of dDNA-dPFK26 and 
dDNA-dPFK27, respectively. dDNAs containing the TDH3 promoter (PTDH3) were PCR amplified 
from genomic DNA of S. boulardii or S. cerevisiae using corresponding primer sets (Table 4.3).  
 
4.2.2 Yeast strain construction and cultivation 
 S. boulardii ATCC MYA-796 and S. cerevisiae S288C strains were starting yeast strains. 
The Cas9-NAT plasmid was introduced into the yeast strains before CRISPR-Cas9 based 
genome editing. YPD medium (10 g/L yeast extract, 20 g/L peptone, and 20 g/L glucose) was 
used for routine yeast culture and CRISPR-Cas9 genome editing. Antibiotics, such as 
nourseothricin (100 μg/mL), geneticin (300 μg/mL), and hygromycin B (200 μg/mL), were 
applied if required. Plasmids and dDNAs were introduced to yeasts using lithium acetate (LiAc)-
polyethylene glycol (PEG) method (Gietz and Schiestl, 2007). gRNA expression plasmids were 
co-transformed with corresponding dDNAs. All pairs of gRNA plasmid and dDNA used in this 
study are described in Table 4.2 and Table 4.3. Correct transformants were screened on YPD 
plates containing proper antibiotics and confirmed by colony PCR. Engineered yeast strains 
were inoculated as initial optical density at 600 nm (OD600nm) 0.1 and cultivated in synthetic 
complete medium (MP Biomedicals, Santa Ana, CA) containing 40 g/L of glucose (SCD) and 50 
mM pH 5.5 potassium hydrogen phthalate (KHP) buffer at 30˚C and 250 rpm. 250 mL of baffled 
flasks were used for 50 mL aerobic cultures. 
 
4.2.3 Quantification of intracellular GDP-mannose and cell wall polysaccharides 
 To measure intracellular GDP-mannose concentrations, yeast cells were harvested in 
1.5 mL tubes from 1 mL of culture broth at the mid-exponential phase and washed with distilled 
water. The cell pellets were thoroughly vortexed with 400 μL of chilled distilled water and 0.1 g 
of glass beads for 30 min. After centrifugation for 10 min at 4˚C and 15,000 rpm, the 
supernatant was analyzed by high performance liquid chromatography (HPLC) equipped with a 
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UV-VIS detector (Shimadzu Scientific Instruments, Kyoto, Japan). Capcell PAK C18 MG column 
(Shiseido, Tokyo, Japan) was eluted with the mobile phase consisting of 20 mM 
triethylamineacetate (98%, v/v) and acetonitrile (2%) at a flow rate of 0.6 mL/min. GDP-
mannose was determined by absorbance at 254 nm.  
To analyze cell wall polysaccharide compositions, yeast cell wall fractions were prepared 
and hydrolyzed, following the procedure described in (François, 2006). Hydrolyzed samples 
were subsequently neutralized and analyzed by HPLC equipped with a refractive-index detector 
(Agilent Technologies, Wilmington, DE, United States) and Rezex RCM-Monosaccharide Ca+2 
column (Phenomenex, Torrance, CA, United States). HPLC grade water was eluted as a mobile 
phase at 0.6 mL/min and 80˚C. 
 
4.2.4 Microscopy analysis of yeast cell walls 
To visualize and analyze structural differences of engineered yeast strains by 
transmission electron microscopy (TEM), yeast strains were aerobically cultured in SCD 
medium containing 50 mM pH 5.5 KHP buffer at 30C for 12 hours from inoculation. The initial 
OD600nm was 0.1. Cells were harvested by centrifuging from 50 mL culture broth and washed 
once with sterilized saline water (0.8 % NaCl2). Fresh wet cell cake was cryopreserved 
according to standard high pressure freeze (HPF) protocol (Hudson et al., 2016), ultrathin 
sectioned after freeze substitution (FS) using acetone and resin, and imaged by Philips CM200 
TEM by the Beckman Institute Image Technology Group in University of Illinois. Thicknesses of 
cell wall layers of engineered yeasts were measures from at least 10 different cells and 25 
different spots using Image J software.   
 
4.2.5 Adhesion test  
S. enterica Typhimurium and E. coli O1:K1:H7 were grown overnight in LB medium 
consisting of 5 g yeast extract, 10 g tryptone, and 5 g NaCl2 per litter. Yeast strains were 
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aerobically cultured in SCD medium with 50 mM pH 5.5 KHP buffer for 12 hours from 
inoculation with initial OD600nm 0.1. Bacterial and yeast cells were harvested by centrifuge and 
washed by sterilized saline water. Adhesion activities between bacterial strains and engineered 
yeasts were determined by the method previously described (Tiago et al., 2012) with small 
modifications. 3  108 CFU/mL of bacterial cells and 3  107 CFU/mL of yeast cells were 
prepared together or separately in 3 mL of sterilized saline water. After brief homogenization by 
vortex, microbial mixtures were incubated at room temperature, and their adhesion and 
sedimentation were observed at every 10 min. 1 mL of supernatant was centrifuged for 5 min at 
700 rpm to collect only bacterial cells in the supernatant by separating unprecipitated yeast cells 
from bacterial cells. The Number of bacterial cells in 500 uL of supernatant was determined by 
measuring OD600nm. Adhesion capacity was defined as numbers of bacterial cells bound to a 
yeast cell and precipitated after clumping. 
 
4.2.6 Analytical methods 
 Concentrations of glucose and products in microbial culture broth were determined by 
HPLC equipped with a refractive index detector (Agilent Technologies) and Rezex ROA-Organic 
Acid H+ (8%) column (Phenomenex). 0.005 N H2SO4 was eluted through the column as a 
mobile phase at 0.6 mL/min and 50˚C. Cell growth was monitored by measuring optical density 
at 600 nm (OD600nm) using UV-visible spectrophotometer (BioMate 5; Thermo Fisher Scientific, 
Waltham, MA, United States). Dry cell weights (DCWs) of each engineered yeast strain were 
determined from a plot of optical density and dry cell weight. To calibrate the plot, engineered 
yeasts were grown in SCD medium, harvested by centrifugation at 10,000 rpm, and washed two 
times with distilled water. Washed cell pellets were resuspended in distilled water to various 
optical densities, and filtrated via thoroughly dried cellulose acetate membrane filters. After cell 
filtration, membrane filters were dried to constant weight in an 80°C convection oven and then 
weighed. 
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4.3 Results 
 
4.3.1 Enhanced GDP-mannose levels in engineered yeasts by interrupting allosteric up-
regulation of upper glycolysis 
 The first step of this study was to increase intracellular levels of GDP-mannose as a 
substrate for cell wall mannan oligosaccharide synthesis. To enhanced metabolic fluxes toward 
GDP-mannose synthesis, PTDH3 replaced promoters of PSA1, SEC53, and PMI40 through the 
CRISPR-Cas9 system. A gRNA plasmid guiding Cas9 endonuclease to the upstream region of 
the target gene and dDNA consisting of PTDH3 and homologous regions were co-transformed 
together into S. boualrdii strain. Resulting strains were named SbP (PMI40 overexpression), 
SbP2 (PMI40 and PSA1 overexpression), and SbP3 (PMI40, SEC53, and PSA1 
overexpression) (Table 4.1). Overexpression of GDP-mannose pathway resulted in slower 
glucose consumption and growth, higher glycerol production and less acetate accumulation 
(Fig. 4.2). These genetic perturbations, however, did not significantly affect GDP-mannose 
levels of S. boualrdii. Interestingly, SbP strain showed lower GDP-mannose content as 
compared to parental S. boulardii (Fig. 4.3). 
PFK26 and PFK27 encoding 6-phosphofructo-2-kinase isozymes, which convert fructose 
6-phosphate into glycolysis up-regulator fructose 2,6-bisphosphate, were scarlessly deleted by 
the CRISPR-Cas9 system to shunt more metabolic fluxes from glycolysis to GDP-mannose 
synthetic pathway in S. boualardii. PFK26 and PFK27 double deletion alone slightly increased 
GDP-mannose levels of engineered S. boulardii, which was named Sbd. PFK26 and PFK27 
were also deleted in GDP-mannose pathway engineered S. boulardii strains and SbPd, SbP2d, 
and SbP3d were prepared (Table 4.1). Co-overexpression of PMI40 and PSA1 synergistically 
increased intracellular GDP-mannose content in the SbP2d strain, while single overexpression 
of PMI40 did not lead statistically significant changes in GDP-mannose levels, as compared to 
 99
Sbd strain. Additional overexpression of SEC53 did not positively affect GDP-mannose levels of 
the SbP3d strain as compared to the SbP2d strain (Fig. 4.3). Phenotypically, PFK26-PFK27 
double deletion led to a higher yield of biomass and acetate, and lower glycerol yield from 
glucose cultures, and accordingly offset previous phenotypic changes of GDP-mannose 
pathway overexpression (Fig. 4.2). Consequently, SbP2d strain achieved the highest GDP-
mannose content, 2.15 mg/g cell, more than 10 times higher than parental strain (Sb, 0.208 
mg/g cell).  
 
4.3.2 Effects of higher GDP-mannose level and mannoprotein overexpression on 
mannan content of S. boulardii cell wall 
 Cell wall fractions from wild-type and engineered S. boulardii strains were collected, and 
its composition was determined after acid hydrolysis and normalized by dry weight of the whole 
cell. Wild-type S. boulardii exhibited 15.1 wt% of cell wall mannan content. Despite its 10 times 
higher intracellular GDP-mannose levels, SbP2d exhibited 18% increase in cell wall mannan 
(17.8 wt%) as compared to wild-type. Sed1p, a cell wall mannoprotein heavily manosylated with 
N-linked mannan, was additionally overexpressed under S. boulardii PTDH3 to maximize the 
effect of abundant GDP-mannose on cell wall mannan synthesis. However, SED1 
overexpression in wild-type (SbS) and high GDP-mannose containing S. boulardii (SbP2d) did 
not lead significant changes in cell wall mannan content (Fig. 4.4). 
 
4.3.3 Effects of additional genetic perturbations on the mannose moiety transport  
 Dolichol-phosphate mannose (Dol-P-man) synthase DPM1, Golgi GDP-mannose 
transporter VRG4, and Golgi guanosine diphosphatase GDA1 were overexpressed in SbP2dS 
to further increase cell wall mannan content by improving the supply of mannose moiety from 
cytosolic GDP-mannose into ER and Golgi, respectively. Additionally, GDA1 was deleted to 
decrease cell wall mannan content as a negative control. The resulting GDA1 deletion strain 
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was named Sb-g. Co-overexpression of SED1 and DPM1 in SbP2d, which efferently 
accumulate GDP-mannose, resulted in 21% and 6% increased cell wall mannan content as 
compared to wild-type S. boulardii and SbP2d strain, respectively. Additional perturbations on 
Golgi GDP-mannose transportation, overexpression of VRG4 and GDA1 did not positively affect 
cell wall mannan contents of engineered strains. On the other hand, GDA1 deletion effectively 
decreased mannan content in wild-type S. boualardii cell wall (Fig. 4.5). In conclusion, 
SbP2dSD strain exhibited the highest cell wall mannan content, 21.5 wt% of cell dry mass.  
 Same metabolic engineering approaches, which led to the highest cell wall mannan 
content in S. boulardii, was repeated in S. cerevisiae S288C strain to compare mannan 
synthesis and containing capabilities of two yeast strains. PTDH3 for overexpression was 
amplified from S. cerevisiae S288C genomic DNA. Same gRNA plasmids and primers were 
used to proceed CRISPR-Cas9 based genome editing, including double deletion of PFK26 and 
PFK27, and overexpression of GDP-mannose pathway, SED1, and DPM1, and deletion of 
GDA1. S. cerevisiae S288C based engineered yeast strains exhibited overall lower mannan 
content than S. boulardii engineered in the same way. Changes in cell wall mannan contents by 
genetic perturbations were marginal as compared to S. boulardii (Fig. 4.6). 
 
4.3.4 Microscopy analysis of yeast cell wall structure  
 To see physical differences of cell wall structures of engineered yeast strains, cell wall 
layers were imaged by TEM and thicknesses of glucan and mannan layers were measured. 
In the comparison of parental strains, S. boulardii exhibited thicker mannan layer and thinner 
glucan layer as compared to S. cerevisiae S288C. Deletion of GDA1 decreased not only 
thicknesses but also densities of mannan layers of both S. boulardii and S. cerevisiae S288C. 
Engineered S. boulardii SbP2d, whose upper glycolysis was down-regulated, interestingly 
increased both mannan and glucan layers, although the glucan biosynthesis was not 
manipulated. SbP2dSD strain exhibited a similar thickness of glucan layer and thicker mannan 
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layer as compared to SbP2d strain (Fig. 4.7 and 4.8). The thickness pattern of mannan layers 
was coherent to the chemical content of mannose in cell wall fraction of engineered yeast 
strains (Fig. 4.8 and 4.9a). 
 
4.3.5 Comparison of adhesion capacities among engineered yeasts with varying 
mannan levels 
 Adhesive interactions between pathogenic bacteria and yeast strains with varying cell 
wall mannan contents were determined by mixing bacterial strains S. enterica Typhimurium and 
E. coli O1:K1:H7 and engineered yeast strains including Sb and Sc strains, their mannan-
defective mutants (gda1) Sb-g and Sc-g, SbP2d and SbP2dSD strain exhibiting the enhanced 
cell wall mannan content. Cell wall mannan contents of yeast strains exhibited a strong positive 
correlation with adhesion capacities against S. enterica Typhimurium (Fig. 4.9b). Adhesive 
activities of yeast strains against E. coli O1:K1:H7 were overall higher as compared to S. 
enterica Typhimurium, but there were no significant differences in adhesive capacities 
depending on the content of cell wall mannan (Fig. 4.9c). 
 
4.4 Discussion 
 I hypothesized that the content of mannan on yeast cell wall mannoprotein is one of the 
most important factors determining levels of probiotic activities of yeasts, and accordingly, 
probiotic activities of yeast can be modulated by metabolic engineering on mannan synthetic 
pathway. GDP-mannose is the only one source of mannose moiety needed for mannosylation of 
yeast proteins so that a defective GDP-mannose supply impaired mannan content in yeast cell 
wall (Orlean, 2012). However, there have not been metabolic engineering approaches in a 
reverse way, namely, improvement of yeast cell wall mannan content by increasing the cellular 
pool of GDP-mannose. The first aim of this study, therefore, was to increase GDP-mannose 
levels in probiotic yeast S. boulardii and study the effect of higher intracellular GDP-mannose 
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levels on cell wall mannan. First, transcriptional levels of GDP-mannose synthetic pathway 
consisting of Mannose 6-phosphate isomerase (Pmi40p), phosphomannomutase (Sec53p), and 
GDP-mannose pyrophosphorylase (Psa1p) was enhanced by substituting strong constitutive 
promoter of TDH3 (PTDH3) for native promoters. To minimize undesirable perturbations on the 
genome, native PTDH3 was inserted in front of target gene coding sequences via the CRISPR-
Cas9 system. The overexpression of GDP-mannose synthetic pathway, however, did not 
significantly increase GDP-mannose levels in S. boulardii.  
As GDP-mannose synthetic pathway is initiated from fructose 6-phosphate by 
isomerization, GDP-mannose production is competing with upper glycolysis (Fig. 4.1). 
Therefore, I hypothesized that fast glycolytic flux through upper part of glycolysis under glucose 
conditions hindered S. boulardii to increase metabolic fluxes toward GDP-mannose through 
overexpressed enzymes. Decreased GDP-mannose level in PMI40 overexpressing S. boulardii 
was an indirect evidence demonstrating that the fast metabolic flux through upper glycolysis led 
to reverse metabolic fluxes from mannose 6-phosphate to fructose 6-phosphate by rapid 
phosphorylation of fructose 6-phosphate during glucose utilization (Zampar et al., 2013) as a 
momentum. 
 To decrease the rate of upper glycolysis and maintain higher steady-state levels of 
fructose 6-phosphate, PFK26 and PFK27, which encode 6-phosphofructo-2-kinase isomers, 
were deleted using the CRISPR-Cas9 system. 6-Phosphofructo-2-kinases synthesize a strong 
up-regulator of the phosphofructokinase (Pfk1p and Pfk2p), fructose 2,6-bisphosphate, from 
fructose 6-phosphate (Boles et al., 1996; Heinisch et al., 1996) (Fig. 4.1). Double deletion of 
PFK26 and PFK27 led to a lack of fructose 2,6-phosphate and accumulation of fructose 6-
phosphate (Boles et al., 1996). With PFK26-PFK27 double deletion, co-overexpression of 
PMI40 and PSA1, encoding the first and the last enzymes of GDP-mannose pathway, 
respectively, significantly improve GDP-mannose levels while single overexpression of PMI40 
was not effective to increase GDP-mannose levels (Fig. 4.3). Additional overexpression of 
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SEC53 did not increase GDP-mannose levels further more. The reversibility of Psa1 reaction 
has been unspecified while Sec53p is known to catalyze reverse reaction from mannose 1-
phophate to mannose 6-phosphate (Boles et al., 1994). This indicated that metabolic 
engineering approaches for both the “push” on fructose 6-phosphate supply and the “pull” on 
GTP transferring were necessary to improve metabolic fluxes toward GDP-mannose. As 
Sec53p also catalyzes isomerization of glucose phosphate (Boles et al., 1994), SEC53 was not 
overexpressed for further genetic perturbations. Although the intracellular GDP-mannose level 
of SbP2d, PFK26-PFK27 double deletion mutant S. boulardii overexpressing PMI40 and PSA1, 
increased 10 times higher, its cell mannan content increased 18% as compared to parent S. 
boulardii (Fig. 4.4). To increase cell wall mannan content further by expanding a foundation area 
of mannosylation, Sed1p, a highly N-glycosylated cell wall mannoprotein, was overexpressed 
under native PTDH3. However, Sed1p overexpression did not lead statistically significant changes 
regarding cell wall mannan.  
Based on the hypothesis that inefficient GDP-mannose supply mechanisms of ER and 
Golgi were major limiting steps, DPM1 and VRG4 were overexpressed under PTDH3 to improve 
mannose moiety transport in ER and Golgi, respectively. Dolichol is a carrier lipid which moves 
mannose moiety into ER by forming a form of Dol-P-man (Orlean, 2012). Dpm1p catalyzes Dol-
P-man synthesis by transferring mannose moiety from GDP-mannose to Dol-P. The mannan 
oligomer elongation in Golgi utilizes GDP-mannose as a donor of mannose moiety, and Vrg4p is 
the representative GDP-mannose transporter in Golgi. In addition, GDA1, which encodes 
guanosine diphosphatase helping Vrg4 to transport GDP-mannose, was also overexpressed 
with DPM1-VRG4 or deleted in wild-type S. boulardii strain to vary cell wall mannan levels of S. 
boulardii further more. SbP2dSD, DPM1 overexpressing SbP2dS strain, exhibited 6% more cell 
wall mannan content than SbP2dS. Overexpression of VRG4 (SbP2dSDV) and VRG4-GDA1 
co-expression (SbP2dSDVG) even resulted in decreased cell wall mannan content as 
compared to SbP2dS and SbP2dSD. However, it is difficult to conclude here that the genetic 
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perturbations on ER and Golgi transport systems were not positive options to increase cell wall 
mannan modulation, because of the complexity of metabolic engineering approaches on the 
GDP-mannose pathway and mannoprotein overexpression. Additionally, as all overexpression 
experiments were done by adding same PTDH3, target genes and TDH3 had to share cellular 
resources for TDH3 single expression, so that target genes could not be fully expressed by 
required levels. It was also possible that the mannan content in the cell wall of SbP2dSD strain 
was close to a physical limitation resulting from the surface area of S. boulardii cell wall (Klis et 
al., 2014). On the other hand, GDA1 deletion clearly showed a negative effect on cell wall 
mannan content without growth defect (Fig. 4.5).  
Same genetic perturbations were reproduced in S. cerevisiae S288C whose native 
mannan content was lower than S. boulardii, around 10 mg/g cell (Fig. 4.6), to see strain 
background effect. Interestingly, S. cerevisiae S288C based engineered strains exhibited overall 
lower cell wall mannan content as compared to S. boulardii based engineered yeasts, and both 
the negative change and the positive change on cell wall mannan were smaller in engineered 
yeasts based on S. cerevisiae S288C (Fig. 4.6). It implied that S. boulardii might have stronger 
capabilities for protein mannosylation that efficiently reflect enhanced GDP-mannose pool and 
cell wall mannoprotein expression. 
Interestingly, genetic perturbations on upper glycolysis and GDP-mannose synthetic 
pathway increased thicknesses of glucan layer as well as mannan layer of engineered Sb 
strains (Fig. 4.7 and 4.8). This could be because of higher availiability of glucose 6-phosphate 
than fructose 6-phosphate in PFK mutant yeast. Previous studies of PFK26-PFK27 double 
deletion in S. cerevisiae demonstrated higher intracellular glucose 6-phosphate levels as 
compared to fructose 6-phosphate (Boles et al., 1996), and this might be because of the 
bidirectional activity of phosphoglucoisomerase and the presence of pentose phosphate 
pathway which is another major metabolism assimilate fructose 6-phosphate. The patterns of 
 105 
glucose 6-phosphate and fructose 6-phosphate in PFK26-PFK27 double deletion S. boulardii 
strains were also coherent with my previous study of PFK1-PFK2 mutant strain SK1 (Fig. 3.6). 
As engineered yeast strains of S. cerevisiae and S. boulardii with varying cell wall 
mannan contents were prepared (Fig. 4.9a), I analyzed correlations between cell wall mannan 
contents and probiotic activities. First, adhesion capacities of engineered yeasts against S. 
enterica Typhimurium were determined. There was a clear positive correlation between the 
adhesion capacities against S. enterica Typhimurium and cell wall mannan contents of yeast 
cells. On the other hand, yeast adhesion capacities against E. coli O1:K1:H7 were not 
significantly changed depending on cell wall mannan contents, although all yeast strains 
exhibited stronger adhesion capacities as compared to S. enterica Typhimurium. This could be 
because of smaller cell size and different characteristics of fimbriae of E. coli O1:K1:H7 (Kisiela 
et al., 2013) 
In conclusion, the content of mannan oligosaccharide on yeast cell wall could be 
modulated by metabolic engineering efforts on GDP-mannose synthetic pathway and 
manipulating expression levels of mannoprotein and mannose moiety transport system for ER 
and Golgi. Same genetic perturbations showed different levels of changes in mannan contents 
in S. boulardii and S. cerevisiae. We finally demonstrated that the adhesion capacity of yeast 
cells has a positive correlation with cell wall mannan content, and adhesion capacities against 
S. enterica Typhimurium can be controlled by manipulating cell wall mannan content. 
 
 
 
  
 106 
4.5 Figures and tables 
 
 
Fig. 4.1 Competition between upper glycolysis and GDP-mannose pathway. Wild-type yeasts 
exhibit rapid glycolytic flux during glucose utilization (a), but the elimination of fructose 2,6-
bisphosphate would slow upper glycolytic flux down and allow GDP-mannose pathway to utilize 
fructose 6-phosphate (b). G6-P, glucose 6-phosphate; F6-P, fructose 6-phosphate; M6-P, 
mannose 6-phosphate; M1-P, mannose 1-phosphate; F2,6-bP, fructose 2,6-bisphosphate; F1,6-
bP, fructose 1,6-bisphosphatre, DHA-P, dihydroxyacetone phosphate; GA3-P, glyceraldehyde 
3-phosphate. 
  
 107 
 
Fig. 4.2 Comparison of culture profiles of engineered S. boulardii under glucose culture 
conditions. 
 
 
 
 108 
 
Fig. 4.3 Intracellular GDP-mannose levels of engineered S. boulardii. O, overexpression; D, 
deletion. 
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Fig. 4.4 Cell wall mannan contents of wild-type (Sb), high GDP-mannose accumulating 
engineered S. boulardii (SbP2d), and their Sed1p overexpression mutants. E, enhanced; O, 
overexpression. 
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Fig. 4.5 Effects of additional engineering for mannose moiety transport machinery. E, enhanced; 
O, overexpression; D, deletion. 
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Fig. 4.6 Comparison between engineered S. boulardii (red) and S. cerevisiae (blue) regarding 
cell wall mannan contents. E, enhanced; O, overexpression; D, deletion. 
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Fig. 4.7 TEM analysis of cell wall structures of yeast strains. Hairy top layers (indicated by green 
lines) are mannan, and solid lower layer (indicated by yellow lines) are glucan layers of yeast 
cell wall.  
  
200 nm
Glucan
Mannan
Sc-g: S. cerevisiae, Δgda1 Sc: S. cerevisiae
Sb-g: S. boulardii, Δgda1 Sb: S. boulardii
SbP2d: S. boulardii, enhanced GDP-mannose pool SbP2dSD: SbP2d, overexpression of SED1 and DPM1
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Fig. 4.8 Analysis of thicknesses of mannan layers and glucan layers of yeast strains. E, 
enhanced; O, overexpression; D, deletion. 
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Fig 4.9 Comparison of cell wall mannan contents of yeast strains (a) and correlations of cell wall 
mannan contents and adhesive capacities of yeast strains against S. enterica Typhimurium (b) 
and E. coli O1:K1:H7 (c). 
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Table 4.1 Strains used in this study 
Name Description Reference 
Sb S. boulardii, ATCC MYA-796 (Liu et al., 2016) 
SbP Sb, PMI40 overexpression under PTDH3 This study 
SbP2 SbP, PSA1 overexpression under PTDH3  This study 
SbP3 SbP2, SEC53 overexpression under PTDH3  This study 
Sbd Sb, PFK26 and PFK27 deletion This study 
SbPd SbP, PFK26 and PFK27 deletion This study 
SbP2d SbP2, PFK26 and PFK27 deletion  This study 
SbP3d SbP3, PFK26 and PFK27 deletion  This study 
SbS Sb, SED1 overexpression under PTDH3 This study 
SbP2dS SbP2d, SED1 overexpression under PTDH3 This study 
SbP2dSD SbP2dS, DPM1 overexpression under PTDH3 This study 
Sb-g Sb, GDA1 deletion This study 
Sc S. cerevisiae S288C (Argueso et al., 2009) 
ScP2d Sc, PMI40 and PSA1 overexpression (PTDH3), PFK26 and PFK26 deletion This study 
ScP2dS ScP2d, SED1 overexpression under PTDH3 This study 
ScP2dSD ScP2dS, DPM1 overexpression under PTDH3 This study 
Sc-g Sc, GDA1 deletion This study 
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Table 4.2 Plasmids used in this study 
Name Description Reference 
Cas9-NAT Cas9 expression plasmid, NAT1 marker (Zhang et al., 2014) 
pRS42K 2µ origin, KanMX EUROSCARF 
pRS42H 2µ origin, hph EUROSCARF 
pRS42K-CS1 pRS42K, gRNA cassette targeting PFK1 This study 
pRS42H-CS2 pRS42H, gRNA cassette targeting PFK2 This study 
pRS42K-PP1 pRS42K, gRNA cassette targeting promoter region of PMI40 This study 
pRS42H-PP2 pRS42H, gRNA cassette targeting promoter region of PSA1 This study 
pRS42K-PP3 pRS42H, gRNA cassette targeting promoter region of SEC53 This study 
pRS42K-PS1 pRS42K, gRNA cassette targeting promoter region of SED1 This study 
pRS42H-PD1 pRS42H, gRNA cassette targeting promoter region of DMP1 This study 
pRS42K-PG1 pRS42K, gRNA cassette targeting GDA1 This study 
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Table 4.3 Primer sets used in this study  
Name Direction Sequence 
gRNA Sense CCCGAGCTCTCTTTGAAAAGATAATGTATGATTATG 
 Antisense AACTGCAGGGATCCAGACATAAAAAACAAAAAAAGCAC 
dDNA-dPFK26 Sense agaagaagggtttattcaagggaacaaaggcaagaggaataaaagctcaagatataaggg 
 Antisense tttaaacgtgactttggctgcgattcatggtttttgcccttatatcttgagcttttattc 
dDNA-dPFK27 Sense aaggaagaaaagggataacgaacgcgttttttccgctggaagtttgaaaaattgaaagca 
 Antisense aactcccgtatggtaaagtatcagtcaagcaaatccgttgctttcaatttttcaaacttc 
dDNA-PP1 Sense tggttattgtagcaattttttgtcgcgtccgtgtcctttttcg CACGCTTTTTCAGTTCG 
 Antisense gcacatacctgcatctaacctgaacagcttgttggacat TTTGTTTGTTTATGTGTGTTT 
dDNA-PP2 Sense aagtgtgcaaactactttacattcgctaactctttttttctgt CACGCTTTTTCAGTTCG 
 Antisense tctggtaccgtaaccaccgactaaaattaaacctttcat TTTGTTTGTTTATGTGTGTTT 
dDNA-PP3 Sense aaactaaatcgacaatttccttagtacttctttctcctttttt CACGCTTTTTCAGTTCG 
 Antisense ttctggtttttccttgtaagcgaattcagcgatactcat TTTGTTTGTTTATGTGTGTTT 
dDNA-PS1 Sense taaatacctgacctattttattctccattatcgtattatctca CACGCTTTTTCAGTTCG 
 Antisense ggctaaaccggcagataataggacagttgataatttcat TTTGTTTGTTTATGTGTGTTT 
dDNA-PD1 Sense tgaaaaattttcagtattcttacgtgttcctaactcatataga CACGCTTTTTCAGTTCG 
 Antisense cttttcatggtaagcgggaacgataacagagtattcgatgctcat TTTGTTTGTTTATGTGTGTTTATTC 
dDNA-PG1 Sense agggtaaggactgcaatcaacaatctttattggcgaacagttaagggt ATAAGAACATGG 
 Antisense cctcttccttaatatacatgggacgaaaagcggtgtccatgttcttat ACCCTTAACTGT 
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Table 4.3 Primer sets used in this study (cont.)  
Name Direction Sequence 
Conf-PFK26 Sense CAAACTCAAGTATTCAGTTACGG 
 Antisense GCATAATTCTTTGGGAAAAAGG 
Conf-PFK27 Sense CGAGTAACACTAAACCGGAAATAC 
 Antisense GTAGCCTTTTCAAGATAACATAATG 
Conf-PP1 Sense GCATAAACCTGTAGCGC 
 Antisense CTGAACAGCTTGTTGGAC 
Conf-PP2 Sense ACAGCAGCTTTGCAACT 
 Antisense TGGCTGGTGTCAAGGTA 
Conf-PP3 Sense CAGCTAGAAATGCCTCGG 
 Antisense GGTCTCAATCTGGTACCG 
Conf-PS1 Sense GCCTTCTTTCGAGGACAA 
 Antisense GTAGTCCAGGCTAAACCG 
Conf-PD1 Sense AGAGGTACGCTCGTG 
 Antisense GGTAAGCGGGAACGA 
Conf-PG1 Sense CAATAGGGTAACGGTATTAATCTC 
 Antisense AGGCCGTTTCAATCCC 
Restriction sites are underlined. Homologous regions for dDNA integration are lowercased.  
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Table 4.4 Target sequences of gRNA used for CRISPR-Cas9 based genome editing in this 
study 
Name Sequence Description 
CS1 TACACAATCTCCACACCATG Near 5’ end of PFK26, Chr IX 
CS2 TCCGATTCAGACTCTCACGA Near 5’ end of PFK27, Chr XV 
PP1 CGATAGCGTTATTACAATAG Promoter region of PMI40, Chr V 
PP2 TCTTAATGTTTCTTCTCGAG Promoter region of PSA1, Chr IV 
PP3 TGGTGGTTATATTAGCAGAT Promoter region of SEC53, Chr VI 
PS1 ACAAGAGAATAGAAAAAGAG Promoter region of SED1, Chr IV 
PD1 CGATAGCGTTATTACAATAG Promoter region of DMP1, Chr XVI 
PG1 TCTTAATGTTTCTTCTCGAG Near 5’ end of GDA1, Chr V 
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CHAPTER V SUMMARY AND FUTURE STUDIES 
 
5.1 Summary 
Saccharomyces cerevisiae, a workhorse yeast strain of biotechnology and food 
industries, has been engineered for the economic production of ethanol. However, this yeast 
has limited capabilities for producing other value-added pharmaceutical and neutraceutical 
molecules, due to a rigid metabolic flux partition toward ethanol during metabolism of 
fermentable sugars, such as glucose. 
Paradoxically, xylose fermentation by engineered yeast harboring heterologous xylose 
metabolic pathways was not as efficient as glucose fermentation for producing ethanol despite 
numerous metabolic engineering efforts. Therefore, I hypothesized that xylose metabolism by 
engineered yeast might be fit better for producing non-ethanol metabolites, which are especially 
derived from cytosolic acetyl-CoA. I indeed found that engineered S. cerevisiae on xylose 
showed higher expression levels of the enzymes involved in ethanol assimilation and cytosolic 
acetyl-CoA synthesis than on glucose. When genetic perturbations necessary for overproducing 
squalene (triterpene) and amorphadiene (sesquiterpene) were introduced into engineered S. 
cerevisiae capable of fermenting xylose, I observed higher titers and yields of isoprenoids under 
xylose than glucose conditions. Specifically, co-overexpression of a truncated HMG1 (tHMG1) 
and ERG10 led to substantially higher squalene accumulation under xylose than glucose 
conditions. In contrast to glucose utilization producing massive amounts of ethanol regardless of 
aeration, xylose utilization allowed much less ethanol accumulation, indicating ethanol is 
simultaneously re-assimilated with xylose consumption and utilized for the biosynthesis of 
cytosolic acetyl-CoA. Also, xylose utilization by engineered yeast with overexpression of 
tHMG1, ERG10, and ADS coding for amorphadiene synthase, and the down-regulation of 
ERG9 resulted in enhanced amorphadiene production as compare to glucose utilization. These 
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results suggest that the problem of the rigid flux partition toward ethanol production in yeast 
during the production of isoprenoids and other acetyl-CoA derived chemicals can be bypassed 
by using xylose instead of glucose as a carbon source. 
To efficiently produce isoprenoid in engineered S. cerevisiae even from glucose, I 
presented a new strategy of manipulating the redox status, instead of regulation of the alcoholic 
fermentation pathway in the yeast. Sesquiterpenes are a natural class of 15 carbon isoprenoids, 
which can be synthesized from farnesyl pyrophosphate, an intermediate of the mevalonate 
pathway and ergosterol biosynthesis in S. cerevisiae. Since the mevalonate pathway and 
Regeneration of NADPH from NADP+ is a prerequisite to overproduce sesquiterpene through 
the mevalonate pathway but the ratio of NADPH and NADP+ tightly regulated by homeostatic 
mechanisms of S. cerevisiae. Oxidative pentose phosphate pathway (oxPPP), which is initiated 
from glucose-6-phosphate, is a major metabolic pathway regenerating NADPH. However, rapid 
metabolic fluxes on upper part of glycolysis and feedback regulation on glucose-6-phosphate 
dehydrogenase do not allow yeasts to increase the metabolic flux partition toward oxPPP. 
Therefore, I have undertaken genetic modifications to modulate the rate of upper glycolysis and 
simultaneously increase cellular activity of glucose 6-phosphate dehydrogenase through 
CRISPR-Cas9 based genome editing. Transcription levels of ZWF1 encoding glucose 6-
phosphate dehydrogenase were increased by introducing strong constitutive promoter in front of 
the ZWF1 coding sequence. The interaction between phosphofructokinase and allosteric up-
regulator fructose 2,6-bisphosphate was interrupted by point mutations on PFK1 (Ser724Asp) 
and PFK2 (Ser718Asp) to decrease the rate of upper glycolysis. Additionally, ERG9 
transcription was down-regulated under weak constitutive promoter to minimize metabolic fluxes 
toward sterols and maximize sesquiterpene synthesis. Phosphofructokinase mutant strains 
showed reduced glycerol yields which demonstrated slow upper glycolysis. ZWF1 
overexpression led synergistic increase of [NADPH]/[NADP+] ratio in phosphofructokinase 
mutant strain, while ZWF1 overexpression alone did not exhibit significant changes in the 
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cofactor ratio. The engineered yeast strain harboring mutant PFK1 and PFK2, and 
overexpressing ZWF1 exhibited the highest amorphadiene after introducing ERG10, tHMG1, 
and ADS overexpression plasmids. 
The strategy of upper glycolysis inactivation was applied on the engineering of probiotic 
yeast S. boulardii. I hypothesized that probiotic activities of S. boulardii could be modulated by 
manipulating metabolic fluxes toward biosynthesis of GDP-mannose, the only mannose moiety 
donor in yeast. The GDP-mannose level in engineered S. boulardii was enhanced by PFK26 
and PFK27 double deletion and overexpression of PMI40 and PSA1. I found that not only the 
“push” on the fructose 6-phopshate steady-state level but the “pull” of metabolic fluxes toward 
GDP-mannose is also critical to successfully increase GDP-mannose levels in yeast. To 
maximize the positive effect of abundant GDP-mannose pool in S. boulardii on its cell wall 
mannan content, proteins involved in mannose moiety transport into ER and Golgi were 
overexpressed together with cell wall mannoprotein Sed1p. Although same genetic 
perturbations were also applied on S. cerevisiae, changes in mannan content of S. cerevisiae 
cell wall fraction was not noticeable, while S. boulardii showed a decent increase in mannan 
contents in its cell wall. I also demonstrated that cell wall mannan content of yeast and probiotic 
activity have a positive correlation. 
 
5.2 Future research directions 
 In chapter II, I found a beneficial transcriptional pattern of yeast for cytosolic acetyl-CoA 
synthesis on xylose. Isoprenoid is one exmaples among various value-added biomolecules 
which can be synthesized from cytosolic acetyl-CoA, and the strategy of xylose utilization can 
be further applied for other acetyl-CoA derivatives, such as medicinal steroids and fatty acids. 
Additionally, I found that another efficient xylose-fermenting yeast of PHO13 deletion could not 
produce isoprenoid from xylose more than parental strain utilizing glucose, although the strain 
was still showing the positive xylose effect on itself. Both TAL1 overexpression and PHO13 
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deletion are well-known strategies to improve xylose-fermenting capabilities of yeast, but no 
studies have delved into their additional effect on acetyl-CoA synthesis. We recently found that 
PHO13 deletion caused low [NADPH]/[NADP+] ratio during xylose utilization. Thus I propose to 
compare two different types of efficient xylose-utilizing strains regarding mevalonate production 
as well as their cellular NADPH availabilities. In chapter III, I showed direct evidence of slow 
upper glycolysis rate and accumulation of sugar phosphate intermediates, but could not show 
that metabolic fluxes on oxPPP and non-oxPPP were increased. A clear analysis of intracellular 
metabolites of oxPPP and non-oxPPP in engineered yeasts of the study is necessary to 
strengthen further the main logic of this study. In chapter IV, simple probiotic activities of 
engineered yeasts, such as adhesion capacities to pathogenic bacteria, were measured. 
Abundant yeast mannan oligosaccharide has additional functions to allow the yeast to be a 
probiotic microorganism, such as activation of immunoglobulin A secretion in mammalian host 
gastrointestinal tracks. I propose animal experiments administrating engineered yeasts 
exhibiting higher mannan oligosaccharide contents.  
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